Obesity

E4_OBESITY

obesity: A disorder involving an excessive amount of body fat.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — E66 Cause of death: ICD-10 — E66 2 out of 7 registries used, show all original rules.	31590
4. Check minimum number of events None	31590
5. Include endpoints E4_OBESITYCAL E4_OBESITYDRUG E4_OBESITYXTRMALV E4_OBESITYNAS	32653
6. Filter based on genotype QC (FinnGen only)	32653

Control definitions (FinnGen only)

Control exclude: E4_OBESITY_HYPER

Extra metadata

Level in the ICD hierarchy: C
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: E65-E68
Name in latin: Obesitas

NAME	E4_OBESITY
CONTROL_EXCLUDE	E4_OBESITY_HYPER
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	E4_OBESITYCAL\|E4_OBESITYDRUG\|E4_OBESITYXTRMALV\|E4_OBESITYNAS
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	E66
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	E66
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Obesity based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	207520	122748	83494
Only index persons	188132	112943	75189
Unadjusted period prevalence (%)
Whole population	3.03	3.52	2.33
Only index persons	3.64	4.15	2.87
Median age at first event (years)
Whole population	48.54	46.90	50.95
Only index persons	47.74	45.65	50.87

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	32653	21669	10984
Unadjusted period prevalence (%)	6.53	7.39	4.84
Median age at first event (years)	50.17	47.47	55.51

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
28806: Matched controls
286782

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

H02AB06

ATC

prednisolone; systemic

1.9

323.0

13439

90815

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

2.7

323.0

4440

18374

R06.5

ICD-10 Finland

Mouth breathing

2.6

323.0

2764

11398

QBJ30

NOMESCO Finland

Correction of abdominal apron

35.6

323.0

830

239

JDF01

NOMESCO Finland

Laparoscopic gastroplasty

1901.1

323.0

707

N05AH04

ATC

quetiapine; oral

2.2

323.0

5316

27056

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

3.6

323.0

2849

8514

S97

ICPC

Chronic ulcer skin

3.5

323.0

1631

4784

N06AX21

ATC

duloxetine; oral

2.4

323.0

3592

16029

J01FF01

ATC

clindamycin; systemic

2.0

323.0

8353

47886

C10AA05

ATC

atorvastatin; oral

1.7

323.0

8787

57826

A10BK01

ATC

dapagliflozin; oral

4.7

323.0

1851

4120

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

2.5

323.0

3505

15295

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.0

323.0

11964

74931

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

3.7

323.0

4775

14700

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

3.4

323.0

2742

8618

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.7

323.0

3964

16105

A10BG03

ATC

pioglitazone; oral

5.8

323.0

1009

1771

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.2

323.0

4663

23132

A10BK03

ATC

empagliflozin; oral

5.0

323.0

3265

7094

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

5.8

323.0

1171

2086

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.8

323.0

13529

93383

A10BB12

ATC

glimepiride; oral

4.8

323.0

2476

5561

A10BJ06

ATC

semaglutide; parenteral

10.6

323.0

2246

2266

27799

ICD-8 Finland

Obesity not specified as of endocrine origin

+∞

323.0

951

XG466

NOMESCO Finland

Sleep oxymetry

6.5

323.0

1607

2593

N02AJ06

ATC

codeine and paracetamol; systemic

1.8

323.0

10886

72819

WX290

NOMESCO Finland

Other blockade of nerve

1.6

323.0

13240

98508

A10BD07

ATC

metformin and sitagliptin; systemic

3.9

323.0

1484

3927

205

Kela drug reimbursment

Chronic hypertension

2.9

323.0

8136

34439

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.3

323.0

3275

14859

C09CA01

ATC

losartan; oral

1.9

323.0

5944

34187

B01AA03

ATC

warfarin; systemic

2.1

323.0

4307

21878

SPAT1262

SPAT

Handing over of treatment supplies

3.5

323.0

7047

24559

J01DA01

ATC

[U] cefalexin; systemic

1.7

323.0

17789

140092

E66.00

ICD-10 Finland

Metabolic syndrome

60.2

323.0

8023

1825

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.4

323.0

3637

16581

A10AE05

ATC

insulin detemir; parenteral

3.4

323.0

2013

6136

N06AX16

ATC

venlafaxine; oral

2.3

323.0

4823

22990

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

5.6

323.0

10624

26923

K02.1

ICD-10 Finland

Caries of dentine

1.6

323.0

16474

129841

215

Kela drug reimbursment

Diabetes, non-insulin-treated

4.5

323.0

10597

32964

E66.01

ICD-10 Finland

Obesity due to excess calories

173.9

323.0

15775

1985

N06AB03

ATC

fluoxetine; oral

2.3

323.0

4067

19270

162

Kela drug reimbursment

liraglutide

19.6

323.0

930

486

E11

ICD-10 Finland

Type 2 diabetes mellitus

4.2

323.0

6359

18034

SPAT1249

SPAT

Treatment-related counselling outside office

1.7

323.0

11356

80493

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

3.7

323.0

5827

18496

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

2.2

323.0

5158

25588

L15

ICPC

Knee symptom/complaint

1.9

323.0

5678

32441

WX780

NOMESCO Finland

Remote monitoring CPAP

4.0

323.0

1513

3940

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

2.7

323.0

8477

38242

A10AE04

ATC

insulin glargine; parenteral

4.0

323.0

3853

10698

N03AX16

ATC

pregabalin; oral

2.0

323.0

6945

38508

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.2

323.0

4007

19390

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

2.5

323.0

3034

12812

E66.8

ICD-10 Finland

Other obesity

249.6

323.0

10089

618

I10

ICD-10 Finland

Essential (primary) hypertension

3.2

323.0

17599

94401

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

3210.5

323.0

2453

R60.0

ICD-10 Finland

Localized oedema

2.7

323.0

3253

12911

I50.0

ICD-10 Finland

Congestive heart failure

3.8

323.0

1717

4762

J01DB01

ATC

cefalexin; oral

2.2

323.0

24151

200072

WX110

NOMESCO Finland

Local anesthesy

1.8

323.0

20059

162128

L17

ICPC

Foot/toe symptom/complaint

1.8

323.0

6873

41533

N02AX02

ATC

tramadol; systemic, rectal

2.3

323.0

13095

76621

R4190

NOMESCO Finland

Nutritional therapy

5.9

323.0

1751

3099

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

5.2

323.0

3944

8487

A10BJ02

ATC

liraglutide; parenteral

15.5

323.0

1853

1262

RD210

NOMESCO Finland

8.3

323.0

1098

1363

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

6.2

323.0

1190

1989

WX722

NOMESCO Finland

PEEP

5.6

323.0

2142

4054

A10BA02

ATC

metformin; oral

5.8

323.0

13080

35901

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.4

323.0

3260

14382

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.1

323.0

5618

30167

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.2

323.0

5381

27095

M54.5

ICD-10 Finland

Low back pain

1.9

323.0

9927

62441

L28

ICPC

Limited function/disability (L)

2.2

323.0

3930

18997

C08CA01

ATC

amlodipine; oral

2.2

323.0

9341

51639

C09AA02

ATC

enalapril; systemic

2.3

323.0

5148

24665

A10BX04

ATC

[U] exenatide; parenteral

20.5

323.0

843

420

M79.6

ICD-10 Finland

Pain in limb

1.9

323.0

10314

66288

R02

ICPC

Shortness of breath/dyspnoea

2.3

323.0

3457

16042

160

Kela drug reimbursment

exenatide

20.0

323.0

1776

940

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

5.5

323.0

1129

2117

C03AA03

ATC

hydrochlorothiazide; oral

2.9

323.0

2695

9978

A10BH01

ATC

sitagliptin; oral

4.9

323.0

4072

9312

S18

ICPC

Laceration/cut

1.7

323.0

10844

75978

G56.0

ICD-10 Finland

Carpal tunnel syndrome

2.2

323.0

4129

20085

E66

ICD-10 Finland

Obesity

16.0

323.0

4334

3144

C03DA01

ATC

spironolactone; oral

3.2

323.0

3298

11174

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.9

323.0

3566

13115

C08CA13

ATC

lercanidipine; oral

2.3

323.0

3330

15252

SPAT1263

SPAT

Sampling

1.7

323.0

12225

85457

I50.9

ICD-10 Finland

Heart failure, unspecified

3.5

323.0

3437

10649

A08AB01

ATC

orlistat; oral

25.2

323.0

581

234

A02BC02

ATC

pantoprazole; systemic

2.0

323.0

18482

136745

E66.9

ICD-10 Finland

Obesity, unspecified

151.9

323.0

5894

485

R06.0

ICD-10 Finland

Dyspnoea

2.5

323.0

7780

37413

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

11.8

323.0

3418

3232

G47.3

ICD-10 Finland

Sleep apnoea

6.3

323.0

11997

29222

R03AC02

ATC

salbutamol; inhalant

2.2

323.0

16660

111503

C03CA01

ATC

furosemide; systemic

3.8

323.0

9205

31661

J45.9

ICD-10 Finland

Asthma, unspecified

2.6

323.0

6084

26629

C09AA05

ATC

ramipril; oral

1.9

323.0

5653

32250

C10AA01

ATC

simvastatin; oral

1.9

323.0

10145

63084

2780A

ICD-9 Finland

Obesity and other hyperalimentation, Obesity

+∞

323.0

793

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

7.8

323.0

3314

4694

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.8

323.0

8030

51189

J01AA02

ATC

doxycycline; systemic

1.8

323.0

21643

180997

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.2

323.0

8647

46157

H03AA01

ATC

levothyroxine sodium; systemic

1.8

323.0

6652

40158

N02BE01

ATC

paracetamol; systemic, rectal

2.7

323.0

25289

207988

C07AB07

ATC

bisoprolol; oral

2.1

323.0

12571

76256

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

3.0

323.0

4166

15358

B01AB05

ATC

enoxaparin; parenteral

2.3

323.0

9398

49071

310

Kela drug reimbursment

Orlistat, sibutramine and other major and expensive medicines used to treat obesity

23.2

323.0

957

424

O24.4

ICD-10 Finland

Diabetes mellitus arising in pregnancy

3.1

323.0

3379

11732

N06AB04

ATC

citalopram; systemic

2.0

323.0

6586

36616

M04AA01

ATC

allopurinol; systemic

3.5

323.0

3998

12614

A10BH05

ATC

linagliptin; oral

4.1

323.0

1439

3624

T90

ICPC

Diabetes non-insulin dependent

4.3

323.0

9508

29354

A10BJ01

ATC

exenatide; parenteral

14.5

323.0

613

428

M10.9

ICD-10 Finland

Gout, unspecified

3.5

323.0

1881

5535

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.4

323.0

4403

19856

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.0

323.0

5560

31248

T82

ICPC

Obesity

14.5

323.0

3478

2696

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.8

323.0

7684

48516

M17.1

ICD-10 Finland

Other primary gonarthrosis

2.3

323.0

5756

28110

A10BX07

ATC

[U] liraglutide; parenteral

21.3

323.0

1085

526

SPAT1310

SPAT

Counselling related to known health issue

1.7

323.0

8993

59782

E66.0

ICD-10 Finland

Obesity due to excess calories

408.3

323.0

1489

OAB72

NOMESCO Finland

Weight control and weight loss guidance

27.6

323.0

552

203

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

580.6

323.0

1393

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

12.0

323.0

3799

3580

103

Kela drug reimbursment

Diabetes, insulin-treated

4.6

323.0

11298

35161

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

6.7

323.0

2166

3456

A46

ICD-10 Finland

Erysipelas

3.2

323.0

4711

16613

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

2.5

323.0

3690

15658

R5140

NOMESCO Finland

Monitoring the use of the aid

5.2

323.0

5321

11887

I48

ICD-10 Finland

Atrial fibrillation and flutter

2.0

320.1

4532

24029

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

4.2

313.5

1282

3157

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

4.0

309.6

1315

3352

E66.1

ICD-10 Finland

Drug-induced obesity

149.6

307.0

327

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

2.5

306.4

2603

10829

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.7

306.3

8612

57602

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

306.3

10084

70515

J96.1

ICD-10 Finland

Chronic respiratory failure

7.5

303.5

752

1023

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

300.4

11444

83084

L03

ICPC

Low back symptom/complaint

1.8

300.1

6763

42242

N06AX12

ATC

bupropion; oral

2.7

298.6

2257

8778

Z3226

NOMESCO Finland

Physiotherapist

1.9

298.5

5137

29272

XCK10

NOMESCO Finland

Photography of fundus of eye

2.4

296.2

2770

12119

R03BA05

ATC

fluticasone; inhalant

1.9

295.8

5278

30455

SPAT1254

SPAT

Administration of medicine

2.1

293.7

3887

19979

C09BA02

ATC

enalapril and diuretics; systemic

2.7

293.4

2179

8380

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

4.4

291.5

1125

2618

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.6

290.8

15560

122641

C02AC05

ATC

moxonidine; oral

3.7

290.8

1379

3865

N03AX12

ATC

gabapentin; oral

2.0

289.9

4307

23187

R03BB04

ATC

tiotropium bromide; inhalant

2.5

289.8

2503

10492

SPAT1305

SPAT

Counselling and guidance related to physical exercise

2.4

288.9

2784

12358

T83

ICPC

Overweight

5.6

286.4

883

1610

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.6

285.8

2340

9519

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

5.0

284.8

969

1978

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

2.5

284.2

2477

10429

WX723

NOMESCO Finland

CPAP therapy

3.8

284.1

1303

3549

N05BA04

ATC

oxazepam; oral

1.7

280.5

6774

43074

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.7

278.3

7431

48670

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.9

277.6

5172

30214

J01FA06

ATC

roxithromycin; oral

1.6

277.0

10984

80037

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

2.3

276.7

2736

12289

J01MA12

ATC

levofloxacin; systemic

1.9

273.7

4720

26815

C09DA01

ATC

losartan and diuretics; oral

2.3

272.3

2738

12396

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

5.8

271.8

813

1428

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.3

271.7

2815

12929

Z3231

NOMESCO Finland

Registered nurse

1.7

270.5

7264

47576

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.9

270.3

4665

26493

EBA00

NOMESCO Finland

Extraction of tooth

1.6

270.3

9059

63089

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.2

268.2

3124

15145

J45.1

ICD-10 Finland

Nonallergic asthma

2.6

265.4

2110

8429

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

263.2

12668

96372

R03AK07

ATC

formoterol and budesonide; inhalant

1.8

262.3

5446

32908

N06AB10

ATC

escitalopram; oral

1.8

261.5

6008

37489

M54.4

ICD-10 Finland

Lumbago with sciatica

1.9

258.7

4630

26592

R03BA02

ATC

budesonide; inhalant

1.8

257.9

4919

28878

M01AE02

ATC

naproxen; oral, rectal

1.5

254.7

15766

126730

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.6

254.6

8278

56973

A10BB01

ATC

glibenclamide; oral

4.4

252.8

983

2301

M01AB05

ATC

diclofenac; systemic, rectal

1.5

252.0

18154

150883

M25.5

ICD-10 Finland

Pain in joint

1.6

249.1

7842

53442

M01AH05

ATC

etoricoxib; oral

1.5

248.5

15958

128998

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

248.3

14195

111772

J45

ICD-10 Finland

Asthma

2.2

247.8

2853

13730

SPAT1301

SPAT

No procedures

1.6

246.6

8189

56568

ZXD05

NOMESCO Finland

Urgent procedure

1.6

245.5

8505

59386

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

244.3

5726

35836

C07AB02

ATC

metoprolol; systemic

1.8

243.3

4590

26783

358

Kela drug reimbursment

liraglutide

18.3

241.0

382

210

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.2

240.7

2641

12425

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

240.0

13522

105792

B03BA03

ATC

hydroxocobalamin; parenteral

3.0

238.1

1482

5076

R05FB02

ATC

cough suppressants and expectorants

1.6

237.3

9552

69092

A10BJ05

ATC

dulaglutide; parenteral

10.8

236.9

472

442

M03BC01

ATC

orphenadrine (citrate); systemic

1.7

236.1

6717

44403

P01AB01

ATC

metronidazole; oral, rectal

1.5

235.7

10851

80976

SGA01

NOMESCO Finland

Tooth opening as first aid

1.8

234.2

4719

28109

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.6

234.2

1931

7854

J01CE02

ATC

phenoxymethylpenicillin; oral

1.5

231.4

19431

165343

C09CA06

ATC

candesartan; oral

1.7

230.6

5473

34295

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

3.1

228.1

1366

4553

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.8

228.0

4464

26313

N06AB06

ATC

sertraline; oral

2.0

227.7

3285

17341

SPAT1240

SPAT

Therapeutic discussion

2.0

227.5

3383

18071

R07.4

ICD-10 Finland

Chest pain, unspecified

1.7

227.1

6416

42251

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.7

226.5

1659

6296

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.2

225.2

2489

11730

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.9

224.8

3533

19267

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.6

223.7

6969

47090

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

7.7

223.1

543

718

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.9

222.3

3468

18853

P76

ICPC

Depressive disorder

2.4

222.2

2057

8891

N05CF01

ATC

zopiclone; oral

1.6

222.0

7797

54318

207

Kela drug reimbursment

Chronic arrhythmias

2.1

221.8

2886

14602

R03DC03

ATC

montelukast; oral

1.8

221.6

4519

26967

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.3

221.4

2262

10268

A02BC01

ATC

omeprazole; systemic

1.6

220.7

6882

46485

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.9

220.1

3409

18476

N05AX12

ATC

aripiprazole; systemic

3.0

220.1

1364

4653

ACC51

NOMESCO Finland

Release of median nerve

2.3

219.4

2156

9600

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.7

219.2

5247

32895

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

3.1

218.8

1300

4307

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

2.8

218.8

1484

5369

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.5

218.7

15962

130886

M03BX02

ATC

tizanidine; oral

1.5

218.5

17071

141986

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.1

217.4

2873

14623

R06AE07

ATC

cetirizine; oral

1.5

216.7

12018

92913

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.5

216.0

10746

81111

M01AE03

ATC

ketoprofen; systemic, rectal

1.5

215.9

9498

69735

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

5.9

214.6

635

1099

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.5

214.1

14637

118149

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.4

211.0

1917

8196

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.0

210.9

3165

16928

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.0

210.6

3149

16821

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.8

210.1

4440

26751

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

3.0

210.1

1299

4420

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.4

208.3

1970

8598

N06AX11

ATC

mirtazapine; oral

1.5

207.8

8233

58858

P06

ICPC

Sleep disturbance

2.0

207.7

2817

14472

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

2.0

207.7

2827

14546

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.6

207.6

6425

43192

M10

ICD-10 Finland

Gout

3.3

207.5

1133

3532

SPAT1229

SPAT

Assessment of need for aid

2.4

207.1

1920

8294

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.6

206.5

6247

41731

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

205.7

4505

27429

C01DA14

ATC

isosorbide mononitrate; oral

2.1

205.7

2723

13850

A28

ICPC

Limited function/disability NOS

2.0

205.3

2955

15545

S76

ICPC

Skin infection other

2.8

204.6

1450

5386

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.8

203.8

3916

22854

A08AA10

ATC

sibutramine; oral

24.1

203.7

295

123

R03AC03

ATC

terbutaline; inhalant

1.8

203.5

3853

22374

SPAT1312

SPAT

General health counselling

1.5

203.4

8620

62526

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.4

203.3

1932

8449

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

202.7

5152

32778

N02AA05

ATC

oxycodone; systemic

1.9

202.3

3198

17426

SAA01

NOMESCO Finland

Simple examination of mouth

1.5

201.6

19652

169580

K04.0

ICD-10 Finland

Pulpitis

2.0

200.7

2967

15761

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.6

200.4

974

2773

A08

ICPC

Swelling

3.1

198.6

1156

3771

A08AA02

ATC

fenfluramine; oral (centrally acting antiobesity products)

8.4

198.5

454

544

M48.0

ICD-10 Finland

Spinal stenosis

2.0

198.5

2689

13796

J46

ICD-10 Finland

Status asthmaticus

3.7

197.4

917

2515

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

197.1

6945

48132

C09DA06

ATC

candesartan and diuretics; oral

2.4

195.8

1863

8146

SPAT1139

SPAT

Nutrition survey

3.3

194.8

1038

3175

J01CA04

ATC

amoxicillin; systemic

1.5

194.0

22535

200925

C09CA03

ATC

valsartan; oral

2.2

193.7

2130

9982

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

192.8

9112

67528

SPAT1260

SPAT

Consultation of another employee

1.7

191.9

4584

28583

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

5.1

191.1

632

1247

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.7

189.6

1409

5381

P03

ICPC

Feeling depressed

2.0

189.6

2772

14641

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.5

189.4

10297

78542

J20

ICD-10 Finland

Acute bronchitis

2.0

188.3

2585

13320

A10BX01

ATC

guar gum; systemic

3.3

187.7

995

3031

R60.9

ICD-10 Finland

Oedema, unspecified

2.8

187.6

1309

4812

N03AX09

ATC

lamotrigine; oral

2.5

187.0

1564

6387

J01MA02

ATC

ciprofloxacin; systemic

1.5

187.0

9359

70097

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.8

185.8

3434

19730

R01AD09

ATC

mometasone; nasal

1.4

185.2

12288

97429

N06AA09

ATC

amitriptyline; systemic

2.0

184.5

2554

13196

E28.2

ICD-10 Finland

Polycystic ovarian syndrome

4.7

183.7

656

1406

N05AA02

ATC

levomepromazine; systemic

2.8

183.7

1247

4505

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.8

183.4

3382

19405

I50

ICD-10 Finland

Heart failure

4.3

182.8

724

1721

SPAT1211

SPAT

Application of soft bandage

2.1

181.1

2363

11913

C08CA02

ATC

felodipine; oral

2.2

180.6

2003

9410

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

179.7

6755

47358

M02AA07

ATC

piroxicam; topical

1.5

179.4

8709

64662

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.9

178.9

2976

16469

A06AD11

ATC

lactulose; oral

1.9

178.5

3013

16759

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

2.0

177.4

2430

12494

L16

ICPC

Ankle symptom/complaint

2.0

177.1

2673

14269

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.6

175.9

5695

38467

R53

ICD-10 Finland

Malaise and fatigue

1.6

175.6

5052

33090

R96

ICPC

Asthma

2.1

175.6

2265

11361

N17.9

ICD-10 Finland

Acute renal failure, unspecified

3.3

175.3

935

2860

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.9

175.2

2904

16041

M70.6

ICD-10 Finland

Trochanteric bursitis

1.9

174.3

2905

16078

A10AD05

ATC

insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

5.4

173.5

549

1030

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.2

173.3

1926

9052

K07

ICPC

Swollen ankles/oedema

3.0

173.3

1048

3506

R4110

NOMESCO Finland

Physiotherapy

1.5

173.3

6501

45486

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

173.0

3195

18318

H02AB07

ATC

prednisone; oral

1.8

172.4

3516

20821

J01FA09

ATC

clarithromycin; systemic

1.5

171.8

8435

62636

H02AB04

ATC

methylprednisolone; systemic

1.7

171.7

3702

22308

S10

ICPC

Boil/carbuncle

2.4

170.8

1519

6403

C10AA07

ATC

rosuvastatin; oral

1.6

169.7

5299

35415

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

2.0

169.4

2446

12823

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.7

168.6

3874

23785

W85

ICPC

Gestational diabetes

2.7

167.2

1250

4784

R05FA02

ATC

opium derivatives and expectorants; systemic

1.4

166.8

10228

79314

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.1

166.6

2054

10101

UJF32

NOMESCO Finland

Coloscopy

1.6

166.4

5909

40743

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.6

165.8

1271

4935

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.9

165.6

2699

14803

N05BA01

ATC

diazepam; systemic, rectal

1.8

164.7

3280

19251

T07

ICPC

Weight gain

5.9

164.6

483

827

R51.80

ICD-10 Finland

Headache

1.7

164.1

4021

25141

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

2.3

163.9

1633

7287

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.7

163.5

3995

24954

R03BA01

ATC

beclometasone; inhalant

1.7

163.5

3566

21533

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

3.2

162.8

928

2978

A12BA01

ATC

potassium chloride; oral

3.1

161.9

938

3046

N05CD07

ATC

temazepam; oral

1.9

161.4

2653

14584

O36.6

ICD-10 Finland

Maternal care for excessive fetal growth

2.8

161.1

1119

4095

W84

ICPC

Pregnancy high risk

2.8

161.1

1130

4158

A10BG02

ATC

rosiglitazone; oral

5.9

161.0

475

819

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

4.3

160.9

626

1462

4019X

ICD-9 Finland

Essential hypertension, Unspecified

4.1

160.8

661

1627

M10.0

ICD-10 Finland

Idiopathic gout

3.5

160.3

803

2339

M79.7

ICD-10 Finland

Fibromyalgia

2.8

159.7

1089

3940

SPAT1283

SPAT

Restricted health certificate

1.6

159.6

5356

36370

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.1

159.3

1899

9196

A10BD03

ATC

metformin and rosiglitazone; systemic

5.5

158.4

489

891

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

2.8

158.2

1125

4175

A02BC05

ATC

esomeprazole; systemic

1.4

157.4

10031

78107

N05AX08

ATC

risperidone; systemic

2.1

157.4

1849

8896

O10.0

ICD-10 Finland

Pre-existing essential hypertension complicating pregnancy, childbirth and the puerperium

4.2

157.1

633

1529

D07AC01

ATC

betamethasone; topical

1.5

156.3

8395

63209

SPAT1255

SPAT

Intravenous administration of medicine

2.2

155.9

1678

7762

Z3229

NOMESCO Finland

Other healthcare associate professional

2.0

155.4

2088

10627

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.1

155.2

1833

8838

Z02.7

ICD-10 Finland

Issue of medical certificate

2.3

154.8

1599

7252

A02BC03

ATC

lansoprazole; oral

1.5

154.3

6894

49927

M54

ICD-10 Finland

Dorsalgia

1.8

154.3

2996

17418

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.1

154.2

1860

9047

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

3.4

153.7

781

2300

SPAT1216

SPAT

Assessment of functional ability

1.8

153.7

3215

19138

E78.29

ICD-10 Finland

Other mixed hyperlipidaemia

6.8

153.5

403

596

B81

ICPC

Anaemia vit B12/folate deficiency

3.0

153.0

926

3098

C01AA05

ATC

digoxin; systemic

2.4

151.9

1352

5692

WZA90

NOMESCO Finland

Other doctors statement

1.5

151.5

5985

42158

A10BH02

ATC

vildagliptin; oral

4.3

151.4

587

1367

177

Kela drug reimbursment

Insulin glargine 300 U / ml

3.8

151.0

683

1829

R03DA04

ATC

theophylline; systemic, rectal

2.6

151.0

1145

4415

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.9

150.5

2270

12079

N62

ICD-10 Finland

Hypertrophy of breast

2.5

148.2

1233

5009

J01CE08

ATC

benzathine benzylpenicillin; parenteral

6.5

148.0

401

619

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

1.7

147.5

3289

19946

D01AC02

ATC

miconazole; topical

2.1

147.2

1891

9442

C07AG02

ATC

carvedilol; oral

2.4

145.6

1300

5482

R05

ICPC

Cough

1.5

145.1

5577

38980

O99.2

ICD-10 Finland

Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium

3.9

144.6

622

1595

C09DA03

ATC

valsartan and diuretics; oral

2.5

144.5

1171

4688

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

4.5

144.4

535

1191

B01AF02

ATC

apixaban; oral

2.1

144.2

1881

9446

H3600, E113

ICD-10 Finland

5.8

144.1

425

733

O13

ICD-10 Finland

Gestational [pregnancy-induced] hypertension

2.4

144.0

1334

5732

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.9

143.2

2478

13840

XF400

NOMESCO Finland

ECG with 12 standard connections

1.7

142.6

3557

22267

M03BC51

ATC

orphenadrine, combinations; systemic

1.5

141.4

7312

54394

3472A

ICD-9 Finland

Cataplexy and narcolepsy[OBSTRUKTIIVINEN UNIAPNEA]

6.0

141.1

409

690

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.9

140.9

912

3189

M01AH01

ATC

celecoxib; oral (coxibs)

1.6

140.6

4226

27808

AN1

Coronary angiography

1.9

140.2

2239

12150

L90

ICPC

Osteoarthrosis of knee

2.3

140.0

1405

6278

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.5

140.0

5521

38768

M01AX17

ATC

nimesulide; oral

1.5

139.3

5536

38934

M01AX05

ATC

glucosamine; oral

1.6

138.8

4037

26333

E0000UV

ATC

1.4

138.6

10023

79327

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.9

138.2

2206

11969

R06.2

ICD-10 Finland

Wheezing

2.5

138.1

1200

4987

Z71.8

ICD-10 Finland

Other specified counselling

1.5

137.9

6164

44455

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.1

137.8

1777

8876

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.2

137.3

1454

6663

F34.1

ICD-10 Finland

Dysthymia

2.6

137.2

1077

4231

LCA06

NOMESCO Finland

Biopsy of endometrium

1.7

136.0

3110

18971

SPAT1153

SPAT

Removal of sutures

1.4

135.6

7375

55317

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.9

135.5

2112

11353

JN3AD

NOMESCO Finland

Abdominal CT examination

2.0

135.5

1807

9151

H3601, E113

ICD-10 Finland

5.0

134.9

452

905

D11

ICPC

Diarrhoea

1.7

134.9

2982

18002

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.7

134.8

1015

3893

S80.0

ICD-10 Finland

Contusion of knee

2.1

134.7

1724

8585

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

133.8

3167

19505

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.6

133.1

3519

22353

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

133.1

6893

51172

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

4.6

132.8

485

1064

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.9

132.5

864

3035

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.4

132.4

6969

51886

WX002

NOMESCO Finland

Sedation and analgesia

1.6

131.6

4481

30357

N18.8

ICD-10 Finland

Other chronic renal failure

3.4

130.3

668

1980

A10BX09

ATC

[U] dapagliflozin; oral

6.2

129.7

366

597

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.3

129.6

1290

5740

AA40B

NOMESCO Finland

10.1

129.3

265

263

SGB10

NOMESCO Finland

Fiiling of rooth of tooth with one root channel

1.7

128.1

2996

18371

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.8

128.0

861

3085

WX320

NOMESCO Finland

Spinalanesthesy

1.5

127.7

5277

37333

A01

ICPC

Pain general/multiple sites

2.0

127.5

1851

9681

B01AF01

ATC

rivaroxaban; oral

1.8

127.4

2391

13700

WZC30

NOMESCO Finland

Teaching

1.7

127.3

3118

19374

D64.9

ICD-10 Finland

Anaemia, unspecified

1.9

126.7

1969

10563

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

2.5

126.2

1052

4272

SGC10

NOMESCO Finland

Covering pulpa of tooth

1.8

125.9

2558

15028

J01FA10

ATC

azithromycin; systemic

1.3

125.6

15714

135225

K04.08

ICD-10 Finland

Other specified pulpit

2.0

125.4

1833

9612

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.9

124.8

1887

10021

A03

ICPC

Fever

1.6

124.6

4204

28373

N06AX03

ATC

mianserin; oral

2.3

124.1

1231

5462

SGC00

NOMESCO Finland

Local medication of root channels of tooth

1.7

123.9

2870

17539

SPAT1097

SPAT

Recording of ECG

1.7

123.7

3176

19981

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.8

123.7

2175

12186

XX_20

NOMESCO Finland

Bioimpedance measurement

50.0

123.2

150

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

2.0

122.5

1623

8186

S29

ICPC

Skin symptom/complaint other

1.6

121.6

3820

25324

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

121.6

5156

36624

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.3

121.2

1184

5216

M01AC06

ATC

meloxicam; systemic, rectal

1.4

120.8

8763

68938

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

6.0

120.5

347

581

R73.0

ICD-10 Finland

Abnormal glucose tolerance test

3.3

119.2

639

1960

L60.0

ICD-10 Finland

Ingrowing nail

2.4

118.8

1114

4809

M01AB01

ATC

indometacin; systemic, rectal

2.0

118.8

1592

8063

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.6

118.4

3472

22608

E000001

ATC

1.5

118.0

5150

36777

R42

ICD-10 Finland

Dizziness and giddiness

1.5

117.9

4678

32725

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.6

117.4

890

3425

J01CF05

ATC

flucloxacillin; systemic

2.5

117.1

994

4075

D07AC13

ATC

mometasone; topical

1.4

117.0

7030

53429

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.6

116.2

3663

24278

Z2446

NOMESCO Finland

Social worker

2.0

116.2

1655

8585

K04.1

ICD-10 Finland

Necrosis of pulp

1.7

115.8

2683

16376

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.8

115.3

2305

13454

SPAT1234

SPAT

Support of social functional capacity

2.3

115.2

1092

4737

SGA03

NOMESCO Finland

Demanding opening and dilatation of root canal of tooth

1.7

115.1

2510

15048

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

114.5

5392

39076

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.0

114.2

1610

8318

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

114.1

4138

28344

I50.1

ICD-10 Finland

Left ventricular failure

2.6

113.6

863

3323

R32

ICD-10 Finland

Unspecified urinary incontinence

3.0

113.4

683

2276

SPAT1104

SPAT

Monitoring of emergency patient

2.0

113.3

1553

7935

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.8

113.2

1975

11022

K42.0

ICD-10 Finland

Umbilical hernia with obstruction, without gangrene

4.7

113.1

402

858

AA1AD

NOMESCO Finland

CT of head and brain

1.5

113.1

4872

34651

O24.1

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, non-insulin-dependent

7.9

112.9

268

342

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.9

112.9

1873

10271

SPAT1281

SPAT

Other administrative function

1.8

112.7

1981

11083

B01AB04

ATC

dalteparin; parenteral

2.3

112.3

1156

5220

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.8

112.0

747

2658

R74

ICPC

Upper respiratory infection acute

1.4

111.6

7648

59390

K08.3

ICD-10 Finland

Retained dental root

2.0

111.5

1601

8327

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

111.3

4369

30447

JJA21

NOMESCO Finland

Laparoscopic biopsy of liver

16.8

111.2

181

108

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

111.0

17389

153324

TPH07

NOMESCO Finland

Cathetrisation of artery

1.8

110.9

2172

12589

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

6.0

110.6

318

532

SFA40

NOMESCO Finland

Replacement of krone of tooth

1.5

110.2

4858

34694

F32.1

ICD-10 Finland

Moderate depressive episode

2.0

110.2

1539

7918

L14

ICPC

Leg/thigh symptom/complaint

1.9

109.8

1651

8735

SPAT1058

SPAT

PEF monitoring instruction

1.8

109.8

1938

10851

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.9

109.6

1722

9257

F61.0

ICD-10 Finland

Mixed personality disorders

3.3

109.6

590

1815

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.0

109.5

1502

7674

R01AD08

ATC

fluticasone; nasal

1.4

109.3

7257

56001

F32

ICD-10 Finland

Depressive episode

2.0

109.1

1455

7350

J01MA14

ATC

moxifloxacin; systemic

1.8

108.9

2035

11614

R03AC13

ATC

formoterol; inhalant

2.2

108.6

1189

5523

N03AG01

ATC

valproic acid; systemic, rectal

2.0

108.6

1551

8048

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.3

107.9

10953

90456

J45.8

ICD-10 Finland

Mixed asthma

2.7

107.8

800

3041

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.7

107.6

2351

14090

R50.9

ICD-10 Finland

Fever, unspecified

1.6

107.5

3217

21016

RD112

NOMESCO Finland

14.3

107.3

186

130

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

3.1

107.3

625

2035

M79.1

ICD-10 Finland

Myalgia

1.6

107.1

3174

20684

N05AF03

ATC

chlorprothixene; systemic

2.7

106.9

786

2972

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.9

106.6

1678

9028

201

Kela drug reimbursment

Chronic cardiac insufficiency

2.5

105.5

875

3538

XG410

NOMESCO Finland

Flow-volume spirometry

2.3

105.0

1004

4371

N06AX26

ATC

vortioxetine; oral

2.0

104.9

1510

7854

XA420

NOMESCO Finland

Extensive sleep examination

4.4

104.6

396

902

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.3

104.2

1023

4513

ZXA00

NOMESCO Finland

Right side

1.4

104.0

5815

43441

N05AN01

ATC

lithium; oral

2.8

103.8

729

2679

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

3.1

103.7

608

1988

R03AC12

ATC

salmeterol; inhalant

2.3

103.7

1007

4419

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.7

103.6

2638

16503

N19

ICD-10 Finland

Unspecified kidney failure

2.9

103.0

663

2309

L08

ICPC

Shoulder symptom/complaint

1.5

102.6

4213

29586

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

2.2

102.6

1126

5232

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

3.0

102.4

637

2168

C02EA02

ATC

2.6

101.1

807

3194

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.0

101.0

1308

6527

D07XC01

ATC

betamethasone, combinations; topical

1.6

100.9

2695

17076

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.9

100.8

1682

9231

ZXE20

NOMESCO Finland

More than three and less than five hours

1.6

100.5

3003

19586

D07BC01

ATC

betamethasone and antiseptics; topical

1.6

100.3

2787

17841

ZY010

NOMESCO Finland

Hospital outpatient

2.0

100.3

1316

6601

H01

ICPC

Ear pain/earache

1.6

100.1

2648

16729

XF402

NOMESCO Finland

ECG with work load test

1.7

99.4

2288

13904

M01AH02

ATC

rofecoxib; oral

1.6

99.4

2762

17679

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

99.1

6722

51891

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.3

99.0

978

4329

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

98.9

9115

73897

A02BA02

ATC

ranitidine; systemic

1.5

98.8

4170

29433

P99

ICPC

Psychological disorders other

2.5

98.3

793

3158

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

98.2

4101

28876

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.4

98.2

5689

42711

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.5

98.1

492

1434

N05AH03

ATC

olanzapine; systemic

1.9

97.5

1505

8028

G44.2

ICD-10 Finland

Tension-type headache

1.5

97.4

3305

22218

P29

ICPC

Psychological sympt/compl other

1.9

97.3

1527

8196

3051

Kela drug reimbursment

16.0

97.1

161

101

N05BA12

ATC

alprazolam; oral

1.7

97.0

2409

14955

SPAT1307

SPAT

Psychosocial counselling and guidance

1.8

97.0

1702

9500

TFP20

NOMESCO Finland

Cardiodefibrillation

2.0

97.0

1388

7201

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

96.9

5541

41485

F50.8

ICD-10 Finland

Other eating disorders

8.0

96.7

226

282

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.7

96.5

2250

13722

C10AB05

ATC

fenofibrate; oral

3.4

96.4

488

1433

L73.2

ICD-10 Finland

Hidradenitis suppurativa

4.3

96.3

376

883

C09CA07

ATC

telmisartan; oral

1.9

96.0

1530

8255

L86

ICPC

Back syndrome with radiating pain

2.0

96.0

1331

6819

R11

ICD-10 Finland

Nausea and vomiting

1.8

95.9

1832

10513

M09AX01

ATC

hyaluronic acid; parenteral

2.2

95.6

986

4450

C03BA11

ATC

indapamide; oral

2.8

95.6

643

2303

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

2.3

95.6

973

4367

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.9

95.4

1531

8284

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

2.1

95.2

1126

5405

N05AB03

ATC

perphenazine; systemic, rectal

2.3

95.1

918

4016

A04

ICPC

Weakness/tiredness general

1.6

95.0

2900

18996

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

95.0

3429

23372

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.6

94.9

2418

15115

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

94.7

7105

55686

J96.0

ICD-10 Finland

Acute respiratory failure

4.8

94.6

327

679

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

3.5

94.4

464

1332

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.6

94.3

2847

18597

SPAT1298

SPAT

Other function in accordance with nutritional therapy nomenclature

4.3

93.9

365

853

N47

ICD-10 Finland

Redundant prepuce, phimosis and paraphimosis

2.8

93.6

653

2391

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

2.3

93.6

943

4209

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

3.5

93.5

453

1285

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

2.1

93.1

1138

5539

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

2.4

93.0

848

3607

ZXE00

NOMESCO Finland

One hour or less

1.3

92.7

9739

80273

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

3.2

92.7

520

1649

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.8

92.4

1873

10950

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.8

92.4

618

2205

JAF30

NOMESCO Finland

Repair of umbilical hernia using prosthetic material

2.9

92.4

588

2032

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.2

92.2

976

4461

M02AA10

ATC

ketoprofen; topical

1.5

92.1

3515

24243

WX725

NOMESCO Finland

Noninvasive ventilation

2.1

91.9

1096

5280

L40.0

ICD-10 Finland

Psoriasis vulgaris

2.1

91.9

1055

4999

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.9

91.5

1450

7805

QBJ05

NOMESCO Finland

Other correction of loose or redundant skin of trunk

50.4

91.5

111

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.3

91.3

8018

64332

40199

ICD-8 Finland

Essential benign hypertension

3.8

90.9

402

1057

K78

ICPC

Atrial fibrillation/flutter

2.0

90.8

1302

6756

C10AX09

ATC

ezetimibe; oral

1.7

90.8

2140

13078

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

3.2

90.3

504

1593

H66.9

ICD-10 Finland

Otitis media, unspecified

1.9

90.2

1432

7715

N06AB05

ATC

paroxetine; oral

1.8

90.1

1560

8661

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.7

90.1

2180

13424

ZXA05

NOMESCO Finland

Left side

1.4

90.0

5352

40273

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.9

89.9

1417

7615

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.7

89.6

1947

11620

SPAT1377

SPAT

Polysomnography

2.3

89.5

858

3737

SPAT1054

SPAT

Examination of peripheral nervous system

3.4

89.4

465

1395

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.0

89.1

1292

6730

N95.0

ICD-10 Finland

Postmenopausal bleeding

1.8

89.1

1682

9608

C07BB07

ATC

bisoprolol and thiazides; systemic

2.3

89.1

867

3807

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.9

88.7

581

2044

EBA30

NOMESCO Finland

Excision of root of tooth

2.0

88.5

1184

5977

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.1

88.4

1062

5131

TQW11

NOMESCO Finland

Vacuum treatment of wound

3.1

88.3

505

1621

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.6

88.1

2271

14225

A10AB06

ATC

insulin glulisine; parenteral

4.3

87.8

342

802

SPAT1094

SPAT

Continuous Positive Airway Pressure

4.1

87.4

356

870

N06AX05

ATC

trazodone; oral

2.5

87.2

699

2773

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.3

86.9

833

3631

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.7

86.4

2069

12695

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

3.2

86.4

482

1523

D07AD01

ATC

clobetasol; topical

1.5

86.1

3491

24361

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

86.0

24801

233782

J02AC01

ATC

fluconazole; systemic

1.3

85.7

10480

87934

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.0

85.3

1118

5598

JDF97

NOMESCO Finland

Other laparoscopic bariatric operation on stomach

+∞

85.3

G04BD12

ATC

mirabegron; oral

1.7

85.1

1910

11505

F31.8

ICD-10 Finland

Other bipolar affective disorders

2.8

84.9

568

2025

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.8

84.7

1497

8368

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

1.8

84.6

1517

8518

P01

ICPC

Feeling anxious/nervous/tense

1.6

84.6

2698

17830

A10BX02

ATC

repaglinide; oral

4.4

84.6

323

743

C09DA07

ATC

telmisartan and diuretics; oral

2.2

84.5

922

4270

C08DB01

ATC

diltiazem; oral

2.2

84.5

901

4131

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.2

84.4

886

4032

A41.9

ICD-10 Finland

Sepsis, unspecified

2.4

84.4

731

3025

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

84.4

7442

59592

C09AA03

ATC

lisinopril; oral

2.2

84.3

943

4417

K85

ICPC

Elevated blood pressure

1.5

84.2

2812

18789

N06AA12

ATC

doxepin; systemic

2.0

84.2

1162

5940

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

2.8

84.2

573

2066

R03AK08

ATC

formoterol and beclometasone; inhalant

2.2

84.0

921

4276

R04

ICPC

Breathing problem other

2.3

83.9

815

3575

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

1.5

83.6

3674

26063

JDF21

NOMESCO Finland

Laparoscopic gastric banding

817.3

83.4

L13

ICPC

Hip symptom/complaint

1.5

83.0

3145

21615

A10AE06

ATC

insulin degludec; parenteral

2.4

82.9

757

3218

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

82.9

2817

18896

SPAT1051

SPAT

Guidance regarding sleep disorders

3.2

82.5

465

1480

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.8

82.3

1582

9086

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

0.5

82.3

782

14615

KGH10

NOMESCO Finland

Operation for phimosis

2.9

81.9

539

1904

R05

ICD-10 Finland

Cough

1.4

81.6

4248

31131

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.0

81.6

1087

5477

N03AX11

ATC

topiramate; oral

2.4

81.2

728

3067

B01AB10

ATC

tinzaparin; parenteral

1.8

81.2

1492

8444

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.5

80.9

2914

19798

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.9

80.6

1231

6534

B02AA02

ATC

tranexamic acid; systemic

1.5

80.6

3634

25895

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

2.4

80.3

704

2933

212

Kela drug reimbursment

Gout

3.4

80.2

409

1209

R52.9

ICD-10 Finland

Pain, unspecified

1.7

80.2

1877

11435

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.0

79.8

1096

5590

B01AC04

ATC

clopidogrel; oral

1.5

79.7

2631

17520

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

2.2

79.6

894

4196

SGA04

NOMESCO Finland

Very demanding opening and dilatation of root canal of tooth

1.5

79.1

2729

18359

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.2

79.0

885

4147

MCA10

NOMESCO Finland

Lower uterine segment caesarean section

1.6

79.0

2494

16429

ZXA10

NOMESCO Finland

Bilateral

1.4

78.7

3884

28156

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.9

78.7

1224

6543

L30.4

ICD-10 Finland

Erythema intertrigo

3.8

78.4

346

909

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.6

78.4

1962

12178

SPAT1325

SPAT

Vaccination

1.3

78.3

7351

59265

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

4.1

78.3

316

767

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

1.9

78.3

1246

6714

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

3.1

78.0

450

1456

RD140

NOMESCO Finland

74.2

78.0

E000003

ATC

2.0

77.8

1109

5737

N05CF02

ATC

zolpidem; oral

1.4

77.8

4119

30252

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

2.5

77.8

647

2622

OAB72

SPAT

7.5

77.7

189

252

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

3.0

77.5

461

1523

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.8

77.4

1426

8074

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

2.5

76.9

615

2439

SPAT1252

SPAT

Overall medication plan or its review

1.8

76.9

1358

7582

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.7

76.8

1643

9748

J01DA06

ATC

[U] cefuroxime; systemic

1.5

76.7

3403

24149

I20.99

ICD-10 Finland

Angina pectoris, unspecified

2.0

76.7

1104

5733

U04

ICPC

Incontinence urine

2.1

76.6

886

4209

M16.1

ICD-10 Finland

Other primary coxarthrosis

1.6

76.5

2028

12778

A10BD20

ATC

metformin and empagliflozin; systemic

4.1

76.3

308

748

R01AD12

ATC

fluticasone furoate; nasal

1.3

76.2

7556

61342

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

1.9

76.1

1187

6347

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.9

76.1

1269

6948

XQ800

NOMESCO Finland

Prick test

1.6

76.1

1905

11820

O82.10

ICD-10 Finland

Delivery by emergency caesarean section

1.8

76.0

1413

8025

NGB40

NOMESCO Finland

Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis

2.7

75.8

562

2136

M47.82

ICD-10 Finland

Other spondylosis, cervical region

2.1

75.5

860

4060

G04BD04

ATC

oxybutynin; oral, transdermal

2.0

75.5

1061

5459

R29

ICPC

Respiratory symptom/complaint other

1.8

75.4

1431

8181

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.9

75.3

1134

5988

R99

ICPC

Respiratory disease other

3.1

75.0

438

1429

SPAT1059

SPAT

Spirometry at the office

1.9

74.9

1123

5920

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.7

74.9

1756

10697

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.6

74.8

566

2176

R04.0

ICD-10 Finland

Epistaxis

1.8

74.7

1332

7459

K77

ICPC

Heart failure

3.5

74.4

364

1043

A99

ICPC

Disease/condition unspecnature/site

1.7

74.3

1675

10089

JAH01

NOMESCO Finland

Laparoscopy

1.9

74.3

1142

6075

D07CC01

ATC

betamethasone and antibiotics; topical

1.5

74.1

2934

20322

E65

ICD-10 Finland

Localized adiposity

35.5

73.9

I25.2

ICD-10 Finland

Old myocardial infarction

2.0

73.8

1055

5463

F50.3

ICD-10 Finland

Atypical bulimia nervosa

5.5

73.7

227

415

RK320

NOMESCO Finland

4.8

73.7

254

527

D07AA02

ATC

hydrocortisone; topical

1.5

73.7

3213

22706

C09BA03

ATC

lisinopril and diuretics; oral

2.8

73.2

496

1785

WX402

NOMESCO Finland

General anaesthesia

1.4

72.7

3847

28217

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.9

72.7

1070

5602

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.5

72.6

2439

16282

EBA15

NOMESCO Finland

Extraction of large number of teeth

2.2

72.5

797

3704

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.2

72.4

816

3834

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

3.1

72.4

415

1337

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

1.6

72.2

2290

15084

Z50.1

ICD-10 Finland

Other physical therapy

1.9

72.1

1192

6503

Z01.2

ICD-10 Finland

Dental examination

1.3

72.1

10336

87894

E03.89

ICD-10 Finland

Other specified hypothyroidism

2.2

72.0

786

3642

N30.0

ICD-10 Finland

Acute cystitis

1.5

71.8

3025

21219

D10

ICPC

Vomiting

1.7

71.8

1487

8732

XF600

NOMESCO Finland

Bloodpressure measurement

1.8

71.7

1335

7581

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.7

71.6

513

1911

K10.3

ICD-10 Finland

Alveolitis of jaws

1.9

71.2

1124

6037

D06AX01

ATC

fusidic acid; topical (antibiotics for topical use)

1.6

71.0

2239

14723

J01FA01

ATC

erythromycin; systemic

1.4

70.8

3531

25604

D05AX52

ATC

calcipotriol, combinations; topical

1.8

70.6

1225

6797

SPAT1251

SPAT

Organisation of medication

2.2

70.5

760

3501

L68.0

ICD-10 Finland

Hirsutism

4.9

70.5

240

492

WX892

NOMESCO Finland

Monitored bed care

1.7

70.4

1510

8960

JAB30

NOMESCO Finland

Repair of inguinal hernia using prosthetic material

0.5

70.1

519

10479

S20

ICPC

Corn/callosity

2.9

70.1

450

1566

D01AC03

ATC

econazole; topical

1.8

69.7

1286

7278

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.2

69.7

739

3379

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

2.2

69.7

778

3638

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.5

69.6

2271

15052

UKC02

NOMESCO Finland

Cystoscopy

1.5

69.6

2873

20062

I48.2

ICD-10 Finland

Chronic atrial fibrillation

2.9

69.6

454

1595

O80.8

ICD-10 Finland

Other single spontaneous delivery

1.9

69.6

1091

5844

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

2.3

69.5

676

2968

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.7

69.4

485

1778

TK800

NOMESCO Finland

Hemodialysis

2.7

69.4

497

1850

X58

ICD-10 Finland

Exposure to other specified factors

1.5

69.2

3104

22042

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

4.5

69.1

256

573

K05.31

ICD-10 Finland

Periodontitis pronounced

1.6

68.8

1996

12855

NG2AA

NOMESCO Finland

Patella X-ray examination

2.4

68.8

592

2440

N97.0

ICD-10 Finland

Female infertility associated with anovulation

2.5

68.7

569

2298

A08AA01

ATC

phentermine; oral

7.2

68.6

171

237

SGB20

NOMESCO Finland

Filling of root of tooth with 2 root channels

1.7

68.5

1512

9044

K04.09

ICD-10 Finland

Pulpit UNS

1.9

68.2

1022

5383

M15

ICD-10 Finland

Polyarthrosis

2.0

68.1

899

4511

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.8

68.0

1309

7511

L01

ICPC

Neck symptom/complaint

1.4

68.0

3104

22112

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

3.0

67.7

407

1357

S21

ICPC

Skin texture symptom/complaint

1.5

67.6

2578

17694

N05BA06

ATC

lorazepam; systemic, sublingual

1.9

67.5

1020

5392

R52.0

ICD-10 Finland

Acute pain

2.2

67.5

755

3534

L02

ICPC

Back symptom/complaint

1.6

67.3

2071

13533

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.0

67.3

890

4468

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.7

67.2

1522

9172

C08CA05

ATC

nifedipine; systemic

1.8

67.2

1223

6890

K86

ICPC

Hypertension uncomplicated

1.6

67.1

2069

13525

UJD02

NOMESCO Finland

Gastroscopy

1.9

66.8

981

5129

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.5

66.6

544

2184

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

1.8

66.6

1278

7328

R03BA08

ATC

ciclesonide; inhalant

1.6

66.5

1863

11893

C10AA04

ATC

fluvastatin; oral

1.7

66.4

1451

8654

N01

ICPC

Headache

1.5

66.1

2455

16746

Z2221

NOMESCO Finland

Medical doctor

1.3

65.9

6599

53423

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

2.1

65.5

770

3683

N06AG02

ATC

moclobemide; oral

1.9

65.5

987

5208

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.5

65.5

558

2291

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

2.1

65.3

810

3964

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.8

65.3

1141

6344

T92

ICPC

Gout

3.0

65.0

389

1292

I20.09

ICD-10 Finland

Unstable angina

1.9

65.0

936

4858

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.3

65.0

624

2723

MAC40

NOMESCO Finland

Pharmacological induction or advancement of labor

2.6

64.7

482

1837

RD250

NOMESCO Finland

+∞

64.5

D02AE01

ATC

carbamide; topical

1.7

64.3

1521

9278

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.6

64.2

506

1990

N04BC05

ATC

pramipexole; oral

1.7

64.1

1424

8528

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

2.7

64.1

470

1776

L12

ICPC

Hand/finger symptom/complaint

1.4

64.0

3104

22350

SPAT1360

SPAT

Extensive global examination

1.7

64.0

1532

9373

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

2.0

63.8

908

4691

I20.90

ICD-10 Finland

Angina pectoris, unspecified

2.3

63.8

612

2666

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.7

63.7

1365

8093

S22

ICPC

Nail symptom/complaint

1.8

63.6

1189

6759

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

2.5

63.5

526

2128

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.6

63.4

2006

13189

TKC20

NOMESCO Finland

Catheterisation of bladder

1.7

63.3

1276

7426

K43.0

ICD-10 Finland

Incisional hernia with obstruction, without gangrene

4.2

63.3

251

601

I42.0

ICD-10 Finland

Dilated cardiomyopathy

2.5

63.2

540

2218

S89.9

ICD-10 Finland

Unspecified injury of lower leg

2.1

63.2

783

3827

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.3

62.7

5157

40558

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.9

62.7

924

4839

C09DX01

ATC

valsartan, amlodipine and hydrochlorothiazide; oral

2.8

62.5

427

1546

H3603, E113

ICD-10 Finland

4.3

62.5

241

562

K59.1

ICD-10 Finland

Functional diarrhoea

1.8

62.4

1058

5821

A10BB07

ATC

glipizide; oral

4.1

62.4

254

623

C07AB03

ATC

atenolol; systemic

1.9

62.3

1015

5508

ZYC01

NOMESCO Finland

Remote contact by phone

1.8

62.3

1038

5679

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.8

62.2

431

1574

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.0

62.1

883

4560

NF1AA

NOMESCO Finland

Hip X-ray examination

1.6

61.9

1522

9384

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

2.0

61.8

802

4000

C08CA10

ATC

nilvadipine; oral

2.8

61.7

418

1505

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.3

61.6

619

2758

R07.3

ICD-10 Finland

Other chest pain

1.6

61.6

1885

12293

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

61.5

658

3019

C09DB01

ATC

valsartan and amlodipine; oral

2.2

61.5

648

2955

SPAT1257

SPAT

Teaching of medicine inhalation technique

2.1

61.5

719

3433

MAC10

NOMESCO Finland

Antepartum dilatation of cervical canal

2.3

61.4

591

2581

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.5

61.4

2570

17966

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.3

61.4

573

2465

ZX120

NOMESCO Finland

Intravenous

1.6

61.3

1946

12799

R03BB01

ATC

ipratropium bromide; inhalant

2.2

61.3

641

2910

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.9

61.3

882

4576

M76.6

ICD-10 Finland

Achilles tendinitis

1.9

61.3

996

5398

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.6

61.2

455

1730

R52.2

ICD-10 Finland

Other chronic pain

2.1

61.2

752

3667

H36.00

ICD-10 Finland

Diabetic background retinopathy

3.1

61.0

355

1158

S02CA02

ATC

flumetasone and antiinfectives; otic

1.8

60.7

1172

6726

A11CC03

ATC

alfacalcidol; systemic

2.5

60.5

487

1939

O24.9

ICD-10 Finland

Diabetes mellitus in pregnancy, unspecified

2.6

60.5

458

1761

R21

ICPC

Throat symptom/complaint

1.3

60.4

4966

39026

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.7

60.3

1400

8491

H25.8

ICD-10 Finland

Other senile cataract

1.6

60.2

1559

9744

H36.09*E11.3

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic retinopathy

5.1

60.1

195

380

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.9

60.1

884

4623

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.5

60.1

2033

13569

Z72.0

ICD-10 Finland

Tobacco use

2.3

60.1

599

2662

K80.8

ICD-10 Finland

Other cholelithiasis

2.8

60.0

395

1398

G04BD08

ATC

solifenacin; oral

1.7

60.0

1212

7059

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.6

59.9

1728

11102

E87.5

ICD-10 Finland

Hyperkalaemia

3.3

59.9

315

956

C07AB05

ATC

betaxolol; oral

2.5

59.7

490

1974

-1

NOMESCO Finland

1.3

59.7

8260

69499

G43.9

ICD-10 Finland

Migraine, unspecified

1.7

59.6

1448

8893

G47.9

ICD-10 Finland

Sleep disorder, unspecified

2.3

59.6

557

2399

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

2.5

59.6

498

2024

N05BE01

ATC

buspirone; oral

2.1

59.6

677

3194

C10AB02

ATC

bezafibrate; oral

3.7

59.5

268

719

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.9

59.5

971

5274

J01FA15

ATC

telithromycin; oral

1.5

59.4

2324

16015

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.7

59.4

1446

8884

SPAT1151

SPAT

Treatment of major wounds

3.5

59.4

295

857

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.2

59.2

647

2998

M54.3

ICD-10 Finland

Sciatica

1.7

58.9

1256

7429

KMAK

NOMESCO Finland

1.2

58.9

13441

119470

WZA00

NOMESCO Finland

Short statement of of health and health related matters

1.7

58.9

1409

8616

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.3

58.8

573

2516

-50

ICPC

Medication/prescr/renewal

1.9

58.8

878

4617

Z2445

NOMESCO Finland

Psychologist

1.9

58.7

968

5273

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.6

58.7

443

1700

G56.2

ICD-10 Finland

Lesion of ulnar nerve

2.1

58.5

725

3544

104

Kela drug reimbursment

Thyroid insufficiency

1.6

58.5

1489

9262

L29

ICPC

Musculoskeletal sympt/complt other

1.6

58.3

1542

9688

A05

ICPC

Feeling ill

1.7

58.3

1359

8251

E03

ICD-10 Finland

Other hypothyroidism

1.7

58.2

1230

7256

SPAT1202

SPAT

Intra-articular injection

2.2

57.9

638

2968

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

3.4

57.9

288

838

N07BB01

ATC

disulfiram; oral

1.8

57.7

976

5365

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

2.2

57.7

609

2779

J96.9

ICD-10 Finland

Respiratory failure, unspecified

5.7

57.7

170

296

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.9

57.6

860

4523

D09AB01

ATC

zinc bandage without supplements; topical

2.6

57.6

438

1691

G03FA14

ATC

dydrogesterone and estrogen; systemic (progestogens and estrogens, fixed comb.)

0.5

57.5

419

8507

TQW80

NOMESCO Finland

Local dermatologic skincare

2.2

57.5

584

2619

E23.04

ICD-10 Finland

Hypogonadotropic hypogonadism

4.1

57.4

232

566

R05DA01

ATC

ethylmorphine; oral

1.6

57.4

1716

11119

K04.00

ICD-10 Finland

Hyperemia of pulp

1.8

57.3

1058

5988

N03AE01

ATC

clonazepam; systemic

1.7

57.3

1225

7254

D07AB08

ATC

desonide; topical

1.5

57.2

2314

16056

F51.0

ICD-10 Finland

Nonorganic insomnia

1.4

57.2

3020

22065

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.5

57.1

2071

14037

F60.9

ICD-10 Finland

Personality disorder, unspecified

2.7

57.0

402

1485

S06

ICPC

Rash localized

1.8

56.9

1114

6422

H36.01

ICD-10 Finland

Diabetic maculopathy

3.3

56.7

301

920

A10BD08

ATC

metformin and vildagliptin; systemic

4.1

56.6

227

550

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.0

56.6

783

4003

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

2.7

56.4

392

1436

N02AJ13

ATC

tramadol and paracetamol; systemic

2.5

56.1

459

1844

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.4

56.0

2888

21001

LCA13

NOMESCO Finland

Curettage of cervix and body of uterus

1.7

55.9

1151

6736

M01AB55

ATC

diclofenac, combinations; oral

1.7

55.9

1298

7868

A10BD15

ATC

metformin and dapagliflozin; systemic

4.4

55.9

210

478

M01AC01

ATC

piroxicam; systemic, rectal

1.4

55.9

2685

19273

F50.4

ICD-10 Finland

Overeating associated with other psychological disturbances

21.2

55.8

SGB30

NOMESCO Finland

Other demanding filling of root channel of tooth

1.4

55.7

2752

19852

Z01.7

ICD-10 Finland

Laboratory examination

1.5

55.6

2346

16410

D01AE15

ATC

terbinafine; topical

1.6

55.6

1368

8431

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.9

55.6

835

4400

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.8

55.6

1095

6326

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

55.4

4346

33859

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.7

55.3

1140

6677

R06AX22

ATC

ebastine; oral

1.3

55.3

4054

31266

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

2.6

55.2

418

1609

A08AA04

ATC

dexfenfluramine; oral

9.4

55.1

116

123

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

2.2

55.0

609

2840

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

3.0

54.9

338

1146

R03AK11

ATC

formoterol and fluticasone; inhalant

2.2

54.4

572

2604

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

1.7

54.1

1113

6513

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.7

54.1

1162

6890

SPAT1285

SPAT

Provision of consultation response

1.7

53.8

1105

6465

R06AX27

ATC

desloratadine; oral

1.3

53.5

6649

55073

G04BD07

ATC

tolterodine; oral

1.8

53.2

886

4843

CK2S4

SPAT

4.3

53.1

202

466

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

2.7

53.1

376

1394

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.4

53.1

2369

16753

C09AA04

ATC

perindopril; oral

1.8

53.0

918

5086

C07FB02

ATC

metoprolol and felodipine; systemic

2.3

53.0

523

2313

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

2.6

53.0

395

1508

K73.80

ICD-10 Finland

Non-alcoholic fatty liver (NASH, Non Alcoholic Steatohepatitis)

7.0

53.0

134

191

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

1.8

52.9

890

4885

XF404

NOMESCO Finland

Ambulatory ECG

1.5

52.8

1738

11521

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

2.6

52.7

410

1603

L89

ICD-10 Finland

Decubitus ulcer and pressure area

3.1

52.6

303

982

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.8

52.5

887

4873

N05AH02

ATC

clozapine; systemic

2.4

52.5

477

2028

K80.5

ICD-10 Finland

Calculus of bile duct without cholangitis or cholecystitis

2.2

52.4

555

2537

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.6

52.3

1438

9124

N91.1

ICD-10 Finland

Secondary amenorrhoea

2.3

52.2

486

2090

Z08

ICPC

Social welfare problem

3.0

52.2

312

1039

N05AE04

ATC

ziprasidone; systemic

3.9

52.1

225

583

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

2.1

52.1

641

3128

K92.1

ICD-10 Finland

Melaena

1.8

52.0

871

4771

A08AX01

ATC

rimonabant; oral

20.5

51.9

D82

ICPC

Teeth/gum disease

1.2

51.9

8469

72319

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.5

51.9

2025

13931

I83.2

ICD-10 Finland

Varicose veins of lower extremities with both ulcer and inflammation

5.0

51.8

173

349

C10AA03

ATC

pravastatin; oral

1.7

51.8

1165

6998

O34.2

ICD-10 Finland

Maternal care due to uterine scar from previous surgery

1.6

51.8

1322

8223

N85.0

ICD-10 Finland

Endometrial glandular hyperplasia

2.6

51.7

407

1602

G57.1

ICD-10 Finland

Meralgia paraesthetica

2.8

51.6

352

1273

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

3.4

51.6

262

776

N06AA06

ATC

trimipramine; systemic

2.2

51.5

557

2571

I11

ICD-10 Finland

Hypertensive heart disease

5.8

51.5

151

262

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.6

51.5

1476

9459

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

3.1

51.5

296

959

Z49.1

ICD-10 Finland

Extracorporeal dialysis

3.0

51.4

303

997

H60.8

ICD-10 Finland

Other otitis externa

2.1

51.3

604

2894

H60

ICD-10 Finland

Otitis externa

1.7

51.1

1016

5882

D35.0

ICD-10 Finland

Benign neoplasm: Adrenal gland

2.7

51.1

355

1301

M54.1

ICD-10 Finland

Radiculopathy

1.9

51.1

826

4471

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

2.5

51.0

406

1608

O61.0

ICD-10 Finland

Failed medical induction of labour

3.1

51.0

296

966

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

2.1

51.0

587

2784

O24.0

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

2.5

50.9

419

1688

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

2.9

50.9

325

1129

B35.6

ICD-10 Finland

Tinea inguinalis [Tinea cruris]

2.7

50.9

352

1286

C07AB08

ATC

celiprolol; oral

2.4

50.8

457

1933

EBA10

NOMESCO Finland

Surgical removal of tooth

1.4

50.7

2888

21353

A29

ICPC

General symptom/complaint other

1.5

50.6

2163

15157

WX111

NOMESCO Finland

Local infiltration anesthesia

2.1

50.5

593

2838

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.1

50.3

590

2822

SPAT1379

SPAT

Health check-up of pregnant person

1.4

50.2

2579

18721

S80.1

ICD-10 Finland

Contusion of other and unspecified parts of lower leg

2.0

50.0

640

3171

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

1.9

50.0

767

4073

7151F

ICD-9 Finland

Osteo-arthrosis and allied disorders, Osteo-arthrosis, localised, primary[OSTEOARTHROSIS PRIMARIA, POLVI]

2.6

49.9

392

1541

ULC02

NOMESCO Finland

Hysteroscopy

1.7

49.8

1132

6822

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

2.1

49.8

586

2807

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.0

49.7

651

3259

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.7

49.7

1132

6826

N07BA03

ATC

varenicline; oral

1.7

49.6

1167

7098

SPAT1284

SPAT

Extensive health certificate

2.0

49.5

665

3360

O80.0

ICD-10 Finland

Spontaneous vertex delivery

0.8

49.5

4088

50456

SPAT1243

SPAT

Psychiatric/psychological examination

2.0

49.4

690

3539

L84

ICD-10 Finland

Corns and callosities

2.0

49.2

674

3433

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

1.9

49.2

788

4249

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.6

49.0

1258

7836

S17

ICPC

Abrasion/scratch/blister

2.3

49.0

471

2058

I48.1

ICD-10 Finland

Persistent atrial fibrillation

2.4

49.0

432

1808

JAG51

NOMESCO Finland

Laparoscopic repair of internal hernia

249.5

49.0

SPAT1357

SPAT

Monitoring of problem during pregnancy

2.0

48.9

646

3244

N06AX22

ATC

agomelatine; oral

2.2

48.9

531

2456

M01AG02

ATC

tolfenamic acid; oral, rectal

1.3

48.8

3651

28194

F32.8

ICD-10 Finland

Other depressive episodes

2.5

48.8

390

1551

NHQ40

NOMESCO Finland

Amputation of toe

2.9

48.7

316

1108

N02AC04

ATC

dextropropoxyphene; oral

2.0

48.7

633

3158

M21.4

ICD-10 Finland

Flat foot [pes planus] (acquired)

2.0

48.7

615

3035

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.8

48.6

952

5487

SPAT1172

SPAT

Guidance concerning hydration

2.6

48.6

381

1497

D05AX02

ATC

calcipotriol; topical

1.9

48.5

800

4359

L11

ICPC

Wrist symptom/complaint

1.5

48.4

1678

11247

T45

ICPC

Metabolic, Observ/health educat/advice/diet

2.7

48.3

338

1245

M09AA72

ATC

quinine, combinations with psycholeptics; systemic

2.3

48.3

484

2157

SFC92

NOMESCO Finland

Other demanding adjuvant procedure of filling therapy

1.6

48.2

1338

8505

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

48.0

9414

81784

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

2.0

47.9

676

3479

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.1

47.8

550

2608

F41.09

ICD-10 Finland

UNS Panic Syndrome

1.9

47.8

686

3557

J01DC02

ATC

cefuroxime; systemic

1.6

47.8

1298

8206

SFA00

NOMESCO Finland

Small filling

1.4

47.8

2841

21146

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.4

47.8

418

1743

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

4.4

47.7

179

408

RD160

NOMESCO Finland

7.9

47.7

111

140

J01

ICD-10 Finland

Acute sinusitis

1.7

47.6

1124

6844

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

2.0

47.6

595

2922

R06AX13

ATC

loratadine; oral

1.3

47.6

3596

27800

XF640

NOMESCO Finland

2.1

47.4

532

2494

H60.3

ICD-10 Finland

Other infective otitis externa

2.2

47.4

492

2230

Z00.0

ICD-10 Finland

General medical examination

1.3

47.1

3879

30360

K03.66

ICD-10 Finland

Tooth plaque

1.6

47.1

1297

8228

D50.8

ICD-10 Finland

Other iron deficiency anaemias

2.7

47.1

325

1186

JAP01

NOMESCO Finland

Laparoscopic freeing of adhesions in the peritoneal cavity

2.4

47.0

398

1632

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

2.7

46.8

337

1263

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

2.2

46.8

495

2263

JAD11

NOMESCO Finland

Laparoscopic repair of incisional hernia

3.1

46.7

268

866

F20.9

ICD-10 Finland

Schizophrenia, unspecified

2.2

46.7

485

2200

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.6

46.7

1134

6961

NHJ10

NOMESCO Finland

Internal fixation of fracture of ankle using wire, rod, cerclage or pin

1.7

46.7

939

5457

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.6

46.6

1131

6941

M77.4

ICD-10 Finland

Metatarsalgia

1.6

46.5

1167

7226

E87.6

ICD-10 Finland

Hypokalaemia

2.0

46.5

582

2862

SPAT1070

SPAT

Doppler ultrasound examination of blood flow in arteries of lower extremity

2.7

46.4

331

1234

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.8

46.3

862

4889

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.3

46.3

435

1880

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.4

46.3

2426

17663

H02BX01

ATC

methylprednisolone, combinations; systemic

1.7

46.2

928

5390

S94

ICPC

Ingrowing nail

2.6

46.2

347

1331

N06AA10

ATC

nortriptyline; systemic

2.2

46.1

498

2298

SPAT1231

SPAT

Assessment of adjustments needed in living environment

2.6

46.1

347

1333

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

2.3

46.1

453

2000

S01

ICPC

Pain/tenderness of skin

1.8

46.1

845

4768

N06AX18

ATC

reboxetine; oral

2.8

45.6

296

1041

EB1CA

NOMESCO Finland

Tooth X-ray additional picture

1.4

45.6

2089

14831

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

1.8

45.5

823

4624

N05AF01

ATC

flupentixol; systemic

2.5

45.5

369

1480

UJF30

NOMESCO Finland

Ileoscopy through colon

1.5

45.5

1920

13415

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.1

45.4

505

2362

D01

ICPC

Abdominal pain/cramps general

1.4

45.3

2330

16899

J31.0

ICD-10 Finland

Chronic rhinitis

1.5

45.2

1658

11246

E86

ICD-10 Finland

Volume depletion

2.4

45.1

388

1602

M43.1

ICD-10 Finland

Spondylolisthesis

1.8

45.1

784

4351

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.5

45.0

1424

9343

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.3

45.0

441

1948

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

3.7

44.9

205

559

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

3.0

44.8

275

933

MAC96

NOMESCO Finland

Other induction or advancement of labour

2.0

44.7

591

2969

M14.6*E11.6

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic neuropathic

8.0

44.7

103

128

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

4.4

44.4

165

373

XG474

NOMESCO Finland

Exhalation nntrogen oxide

2.0

44.3

616

3158

N06AA04

ATC

clomipramine; systemic

2.4

44.0

397

1682

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.5

44.0

1447

9577

-45

ICPC

Observ/health educat/advice/diet

1.9

44.0

681

3630

O82.0

ICD-10 Finland

Delivery by elective caesarean section

1.7

44.0

1023

6203

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.6

43.8

330

1270

K59.09

ICD-10 Finland

Constipation, unspecified

1.7

43.7

1044

6375

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.7

43.7

968

5791

R10.0

ICD-10 Finland

Acute abdomen

1.9

43.7

662

3502

Angiography of the heart and coronary arteries

1.7

43.7

881

5127

R60.1

ICD-10 Finland

Generalized oedema

4.0

43.6

182

459

JKA20

NOMESCO Finland

Cholecystectomy

2.2

43.6

471

2175

S91.3

ICD-10 Finland

Open wound of other parts of foot

2.1

43.5

494

2329

K04.7

ICD-10 Finland

Periapical abscess without sinus

1.6

43.5

1148

7202

Z71.9

ICD-10 Finland

Counselling, unspecified

1.6

43.4

1170

7380

N05AD01

ATC

haloperidol; systemic

2.0

43.4

547

2694

N17

ICPC

Vertigo/dizziness

1.4

43.4

2023

14402

T78.4

ICD-10 Finland

Allergy, unspecified

1.7

43.4

1029

6272

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.8

43.2

749

4153

I21.49

ICD-10 Finland

Acute subendocardial infarction unspecified coronary artery status

1.8

43.2

808

4594

N05BB01

ATC

hydroxyzine; systemic

1.6

43.1

1326

8640

JAF10

NOMESCO Finland

Repair of umbilical hernia

2.1

43.1

488

2299

WX872

NOMESCO Finland

Intensive care

1.7

42.9

890

5222

R28

ICPC

Limited function/disability (R)

2.9

42.9

263

893

R35

ICD-10 Finland

Polyuria

1.6

42.8

1099

6845

E78.11

ICD-10 Finland

Other hypertriglyceridemia

4.6

42.8

154

338

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.0

42.7

599

3079

Z32.1

ICD-10 Finland

Pregnancy confirmed

1.4

42.7

2186

15840

R75

ICPC

Sinusitis acute/chronic

1.7

42.6

1015

6196

M54.8

ICD-10 Finland

Other dorsalgia

1.7

42.5

831

4787

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.6

42.4

1202

7678

P74

ICPC

Anxiety disorder/anxiety state

1.7

42.4

865

5047

I80.0

ICD-10 Finland

Phlebitis and thrombophlebitis of superficial vessels of lower extremities

1.8

42.3

722

3983

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

2.0

42.3

525

2574

K80.1

ICD-10 Finland

Calculus of gallbladder with other cholecystitis

2.1

42.2

468

2187

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

42.1

562

2835

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

2.4

42.1

382

1625

M47.9

ICD-10 Finland

Spondylosis, unspecified

1.9

42.0

608

3163

QBJ00

NOMESCO Finland

Liposuction in trunk

4.2

42.0

163

385

W19

ICD-10 Finland

Unspecified fall

1.5

42.0

1769

12349

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.0

42.0

586

3007

A12AA04

ATC

calcium carbonate; oral

2.6

41.9

314

1204

JAF11

NOMESCO Finland

Laparoscopic repair of umbilical hernia

4.0

41.9

175

442

E000006

ATC

1.5

41.9

1452

9724

63703

ICD-8 Finland

Pre-eclampsia, eclampsia and toxaemia, unspecified, Prae-eclampsia levis

2.6

41.9

315

1212

R78

ICPC

Acute bronchitis/bronchiolitis

2.1

41.9

465

2172

I89.0

ICD-10 Finland

Lymphoedema, not elsewhere classified

3.7

41.9

191

521

I21.41

ICD-10 Finland

Acute subendocardial infarction stenosed coronary artery

1.8

41.8

709

3901

N06AB08

ATC

fluvoxamine; oral

1.9

41.7

591

3053

D01BA02

ATC

terbinafine; oral; topical

1.3

41.7

5096

41922

G93.2

ICD-10 Finland

Benign intracranial hypertension

6.6

41.7

109

164

C01BD01

ATC

amiodarone; systemic

2.1

41.6

471

2221

N18.0

ICD-10 Finland

End-stage renal disease

3.1

41.6

239

776

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.6

41.5

1043

6461

G03DB01

ATC

dydrogesterone; oral

1.3

41.5

3138

24222

R31

ICD-10 Finland

Unspecified haematuria

1.5

41.4

1563

10661

L30.3

ICD-10 Finland

Infective dermatitis

1.8

41.4

685

3736

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

2.3

41.4

394

1715

EMB10

NOMESCO Finland

Tonsillectomy

1.5

41.2

1390

9250

F31

ICD-10 Finland

Bipolar affective disorder

2.6

41.2

314

1218

K29.7

ICD-10 Finland

Gastritis, unspecified

1.9

41.1

657

3542

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

2.1

41.1

476

2266

C03EA02

ATC

trichlormethiazide and potassium-sparing agents; oral

2.6

40.7

313

1218

F33

ICD-10 Finland

Recurrent depressive disorder

2.1

40.7

474

2265

R07

ICPC

Sneezing/nasal congestion

1.5

40.6

1453

9800

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

1.9

40.5

622

3305

K28

ICPC

Limited function/disability (K)

2.4

40.5

342

1400

C07AA05

ATC

propranolol; systemic

1.3

40.4

4360

35313

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

2.1

40.3

480

2312

ECB00

NOMESCO Finland

Suture of gingiva

1.8

40.3

719

4027

SPAT1167

SPAT

Insertion of urinary catheter

2.1

40.2

486

2356

NG1DA

NOMESCO Finland

X-ray of knees

2.3

40.2

371

1592

B35.3

ICD-10 Finland

Tinea pedis

1.8

40.2

764

4364

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

1.6

40.1

1093

6910

F60.8

ICD-10 Finland

Other specific personality disorders

3.4

40.0

202

598

AA43B

NOMESCO Finland

25.4

40.0

NG4AA

NOMESCO Finland

Lower leg X-ray examination

1.9

40.0

581

3029

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

1.9

39.9

609

3231

A10AD01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

2.3

39.9

370

1593

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

2.0

39.8

539

2734

S82.6

ICD-10 Finland

Fracture of lateral malleolus

1.6

39.8

1180

7621

L40.9

ICD-10 Finland

Psoriasis, unspecified

2.5

39.7

319

1274

Z98.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3033658) Prothrombin time (PT) actual/Normal

9441

64298

1.64

321.17

4.5

3.8

92.8

92.7

0.26

9149

62620

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

29311

262869

2.02

315.47

5.5

4.0

mmol/l

1.3

1.5

307.65

27526

245860

(3000991) Gas panel - Venous blood

3655

18828

2.04

315.44

10.2

8.5

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

3355

16767

2.09

314.26

4.6

3.9

ng/l

104.3

85.5

18.39

2933

14691

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

29445

264660

2.04

312.31

5.5

4.0

mmol/l

4.4

4.8

307.65

27803

248437

(3026782) Osmolality of Urine

7339

47219

1.70

309.12

3.1

2.6

mosm/kgh2o

561.9

541.2

9.45

6295

40188

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

22703

185606

1.69

307.65

4.0

2.9

u/l

56.7

43.3

76.80

21350

175177

(42870588) Differential panel, method unspecified - Blood

12389

88163

1.63

307.65

6.1

6.0

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

3968

13196

3.25

307.65

3.8

3.4

kpa

5.3

5.1

34.19

3710

12198

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

4505

21774

2.22

307.65

2.3

g/l

0.2

0.25

4200

20368

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

16298

96333

2.35

307.65

2.5

1.8

pmol/l

94.9

97.6

10.44

9763

50070

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

26109

211594

2.11

307.65

5.0

4.0

pmol/l

14.6

0.22

24251

194861

(3018010) Neutrophils/100 leukocytes in Blood

16524

127255

1.58

307.65

6.5

5.8

58.8

56.7

113.82

15527

119621

(3019060) Gas panel - Arterial blood

3055

13887

2.30

307.65

5.2

4.9

—

(3013707) Erythrocyte sedimentation rate by Westergren method

23567

196965

1.66

307.65

4.7

3.9

mm/h

15.8

10.7

307.65

21966

183727

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

16798

106081

2.17

307.65

3.0

2.2

nmol/l

70.5

923.7

0.50

15550

96821

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

18988

129801

2.07

307.65

5.8

6.1

umol/l

10.6

11.0

3.59

18006

122819

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

9549

57782

1.90

307.65

2.0

1.7

mg/l

1.0

1.1

1.36

7447

43498

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

29131

249455

2.45

307.65

6.2

4.6

mu/l

2.1

0.17

27372

231741

(3036481) Cortisol [Moles/volume] in Serum or Plasma

5105

23409

2.37

307.65

2.1

2.2

nmol/l

339.5

379.4

38.11

4635

21672

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

12561

88407

1.66

307.65

3.8

3.2

—

0.3

—

(3019198) Lymphocytes [#/volume] in Blood

17890

136774

1.65

307.65

6.5

5.9

e9/l

2.0

1.9

8.40

15925

121599

(3015377) Calcium [Moles/volume] in Serum or Plasma

12073

82321

1.72

307.65

3.0

3.4

mmol/l

2.3

2.4

15.25

10589

72701

(1002224) Polysomnography panel

2567

11380

2.34

307.65

1.1

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

4192

20109

2.22

307.65

4.8

3.9

kpa

6.0

5.8

18.98

4076

19543

(3026493) Urate [Moles/volume] in Serum or Plasma

12270

64103

2.43

307.65

2.9

2.4

umol/l

3679.7

3707.8

0.03

10745

56384

(3022313) Gas panel - Capillary blood

2992

9235

3.43

307.65

3.7

3.6

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

30523

272090

2.70

307.65

23.2

13.5

mmol/l

4.0

3.9

43.40

30034

264676

(3013512) EKG study

10302

67000

1.76

307.65

4.7

3.5

—

(3002032) Base excess in Venous blood by calculation

4155

20075

2.20

307.65

4.8

4.0

mmol/l

2.0

1.8

4.27

3459

16424

(3009343) pH of Capillary blood

3936

13015

3.27

307.65

3.8

3.4

7.4

5.47

435

1755

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

28684

253476

1.99

307.65

4.9

3.6

mmol/l

1.6

1.3

307.65

26751

236037

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

29356

237341

3.23

307.65

9.1

4.9

mmol/mol

42.9

38.7

307.65

27939

221586

(3012095) Magnesium [Moles/volume] in Serum or Plasma

8093

37417

2.52

307.65

3.2

3.6

mmol/l

0.8

1.36

7657

34947

(3019309) Folate [Moles/volume] in Red Blood Cells

8140

39424

2.39

307.65

2.1

1.7

nmol/l

1209.7

1160.1

5.04

6612

29905

(3044640) Blood type and Crossmatch panel - Blood

12300

81803

1.78

307.65

2.5

2.3

—

(3031040) Bacteria [#/volume] in Urine by Automated count

21563

174239

1.66

307.65

5.3

4.1

e6/l

1362.8

1417.6

0.05

345

2154

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

5744

32977

1.88

307.65

1.9

1.8

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

29351

255622

2.35

307.65

6.2

4.0

mmol/l

6.4

5.8

307.65

27440

236458

(3037467) Urinalysis macro (dipstick) panel - Urine

22727

183451

1.75

307.65

5.0

4.1

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

2568

8215

3.27

307.65

3.9

3.7

mmol/l

24.9

24.8

1.37

2412

7614

(3003396) Base excess in Arterial blood by calculation

4881

24840

2.11

307.65

8.7

7.3

mmol/l

1.4

0.9

11.52

3970

19427

(3016244) Insulin [Units/volume] in Serum or Plasma

1166

1270

9.39

307.65

4.2

2.6

mu/l

42.2

17.2

43.01

1120

1179

(3012516) Albumin [Mass/volume] in Urine

13993

64667

3.00

307.65

3.7

3.2

mg/l

234.5

451.3

10.11

9714

40174

(3026008) Bacteria identified in Urine by Culture

11145

72917

1.78

307.65

3.4

2.8

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

17456

122792

1.88

307.65

3.8

2.8

ug/l

112.1

110.1

0.26

16384

115118

(3027801) Oxygen [Partial pressure] in Arterial blood

4885

24826

2.12

307.65

8.6

7.4

kpa

11.0

13.0

163.81

4677

23724

(3006504) Eosinophils/100 leukocytes in Blood

16316

124204

1.60

307.65

6.6

6.0

2.8

3.08

15274

116127

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

13946

86600

2.04

307.65

3.4

3.2

u/l

32.5

32.7

0.13

13219

82370

(3016502) Oxygen saturation in Arterial blood

4355

22187

2.09

307.65

9.0

7.8

94.6

96.0

37.57

4221

21333

(3001604) Monocytes [#/volume] in Blood

17473

132239

1.66

307.65

6.4

5.9

e9/l

0.6

70.54

15282

115445

(3013826) Glucose [Moles/volume] in Serum or Plasma

21676

146261

2.39

307.65

6.2

4.4

mmol/l

7.2

6.5

237.04

20339

134969

(3019069) Monocytes/100 leukocytes in Blood

16408

124872

1.61

307.65

6.9

6.3

8.1

8.4

51.52

15452

117466

(3013115) Eosinophils [#/volume] in Blood

18059

137297

1.68

307.65

6.8

6.1

e9/l

0.2

33.77

16029

121660

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

13212

88760

1.80

307.65

4.4

3.1

ng/l

52.2

61.9

0.42

8727

53499

(3020682) Albumin/Creatinine [Ratio] in Urine

14706

67782

3.09

307.65

4.7

3.9

mg/mmol

11.7

8.9

7.61

10179

42327

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

4887

24842

2.11

307.65

8.7

7.4

kpa

5.3

5.0

63.20

4691

23745

(3006315) Basophils [#/volume] in Blood

17568

132803

1.67

307.65

6.4

5.9

e9/l

0.0

7.32

15331

115873

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

9306

61986

1.68

307.65

2.4

2.2

—

(3022217) INR in Platelet poor plasma by Coagulation assay

4925

27658

1.90

307.65

25.6

20.5

inr

1.3

0.86

619

4184

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

29836

268370

2.17

307.65

6.0

4.4

mmol/l

2.6

2.8

253.38

28073

250333

(3032080) INR in Blood by Coagulation assay

14556

93488

1.98

307.65

10.0

7.5

inr

1.2

1.67

4110

28172

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

12250

79576

1.84

307.65

2.8

2.5

u/l

50.2

58.7

18.89

11353

73576

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

6250

36711

1.85

307.65

2.0

1.8

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

1014

2546

4.04

307.65

1.2

1.3

nmol/l

27.0

29.3

0.13

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

25579

198179

2.28

307.65

8.4

7.3

u/l

81.3

76.0

61.52

24426

186864

(3007853) Bacteria identified in Skin by Aerobe culture

5869

29408

2.19

307.65

2.0

1.7

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

30494

271253

2.71

307.65

23.0

13.4

mmol/l

139.7

139.6

3.92

30048

264375

(3014576) Chloride [Moles/volume] in Serum or Plasma

5584

27731

2.20

307.65

7.9

7.2

mmol/l

104.3

104.6

4.26

5462

27165

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

17898

119333

2.07

307.65

8.2

6.4

mmol/l

1.2

25.47

15413

100863

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

17082

125685

1.73

307.65

4.5

3.9

—

(3021960) Folate [Moles/volume] in Serum or Plasma

9611

52259

2.16

307.65

1.8

1.5

nmol/l

20.4

0.18

8539

45122

(3003458) Phosphate [Moles/volume] in Serum or Plasma

7254

28616

2.94

307.65

6.1

6.0

mmol/l

1.1

1.0

35.10

6900

26780

(3024354) Oxygen [Partial pressure] in Venous blood

3444

16345

2.21

307.65

4.1

3.3

kpa

4.8

4.6

3.56

3332

15827

(3042936) Bacteria identified in Isolate by Culture

6291

34164

2.02

307.65

2.4

2.0

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

6308

31471

2.22

307.65

3.1

2.5

20.7

23.6

53.89

5509

27011

(3024561) Albumin [Mass/volume] in Serum or Plasma

17639

103398

2.50

307.65

5.4

4.7

g/l

35.5

36.0

36.67

16677

96000

(3022096) Basophils/100 leukocytes in Blood

15790

120305

1.58

307.65

6.7

6.1

0.6

0.7

34.43

14779

112527

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

30044

271348

2.21

307.65

20.0

12.3

mg/l

21.5

22.2

2.91

27232

209779

(3012544) pH of Venous blood

4303

20833

2.20

307.65

4.7

4.0

7.4

0.30

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

8825

49662

2.04

307.65

2.0

1.6

pmol/l

30349983.7

38735424.2

0.67

7552

41802

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

10952

60284

2.20

307.65

2.6

2.2

mg/l

3.2

2.8

53.26

9689

51595

(3009508) Creatinine [Moles/volume] in Urine

14803

72378

2.88

307.65

3.7

3.2

mmol/l

7.9

0.03

12503

61542

(3023368) Bacteria identified in Blood by Culture

10536

60897

2.05

307.65

4.9

4.1

—

(3022948) Iron [Moles/volume] in Serum or Plasma

7220

37487

2.16

307.65

3.0

2.4

umol/l

12.5

14.3

3.09

6705

34863

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

3812

12556

3.27

307.65

3.7

3.4

mmol/l

1.8

1.6

3.84

2882

9159

(3002030) Lymphocytes/100 leukocytes in Blood

16735

129074

1.58

307.65

6.7

6.0

27.1

28.8

85.83

15686

120832

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

11413

58389

2.44

307.65

3.5

2.8

ng/l

1231.6

1142.8

1.31

9437

49439

(3018418) pH of Serum or Plasma

10500

70853

1.69

307.65

4.8

4.0

7.4

0.55

1994

13470

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1573

5002

3.22

307.65

2.4

ug/min

146.5

99.8

2.68

967

3019

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

16322

107869

2.00

307.65

7.5

5.7

mmol/l

1.2

22.86

15031

98026

(3004789) Transferrin [Mass/volume] in Serum or Plasma

6748

34290

2.20

307.65

3.0

2.4

g/l

2.5

2.4

40.62

6231

31817

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1500

4447

3.45

307.65

1.9

2.3

nmol/l

1.1

0.8

23.59

1196

3797

(3013650) Neutrophils [#/volume] in Blood by Automated count

19421

152787

1.64

307.65

9.3

9.0

e9/l

4.6

4.0

243.36

17084

134155

(3020779) Urea [Moles/volume] in Serum or Plasma

3996

19489

2.17

307.65

9.4

7.7

mmol/l

11.0

8.9

52.98

3815

18645

(3002582) Erythrocytes [#/volume] in Urine

10541

74599

1.59

301.84

3.6

3.1

e6/l

74.5

78.9

0.12

8223

56507

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1495

5283

2.89

300.31

3.6

2.8

mmol/l

25.2

24.5

6.06

1333

4624

(3018095) Leukocytes [#/volume] in Urine

12176

89651

1.55

289.96

4.2

3.5

e6/l

86.1

83.4

0.15

8793

61466

(40768797) Stomach Pathology biopsy report

5671

34698

1.75

283.64

1.2

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

3829

20779

1.93

282.63

9.9

8.1

g/l

124.5

121.5

14.19

3731

20012

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

1272

4264

3.03

280.62

3.6

3.0

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

10192

72519

1.57

280.24

2.3

2.1

u/l

194.6

197.8

0.12

9586

68265

(3014111) Lactate [Moles/volume] in Serum or Plasma

3666

19685

1.95

278.99

8.8

7.1

mmol/l

1.4

1.3

6.58

3516

19036

(3030467) Casts [#/volume] in Urine by Automated count

9689

68282

1.58

277.12

3.5

3.0

e6/l

0.5

0.4

4.75

7409

50656

(4146454)

809

2048

3.99

276.28

2.7

2.8

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

9481

66543

1.58

275.74

1.7

1.6

mmol/l

1.7

1.3

141.96

7972

56732

(3027273) Bicarbonate [Moles/volume] in Venous blood

2229

9976

2.30

273.64

4.1

3.3

mmol/l

25.4

25.2

1.94

2173

9666

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

28141

251445

1.78

272.30

17.5

11.2

ml/min/173m2

85.5

85.4

0.20

24059

206320

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2093

9169

2.35

269.95

5.0

3.7

50.3

48.9

1.69

2067

9069

(3015736) pH of Urine

13321

101173

1.51

268.30

3.9

3.1

5.8

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

764

1898

4.06

267.72

1.5

1.3

nmol/l

1.7

1.4

12.41

707

1701

(3004119) Hemoglobin [Mass/volume] in Venous blood

2660

12924

2.13

266.31

4.2

3.3

g/l

130.2

129.6

0.62

2596

12627

(3035350) Ketones [Presence] in Urine by Test strip

16492

131058

1.50

265.60

4.3

3.3

estimate

0.0

2.75

3328

24532

(3009261) Glucose [Presence] in Urine by Test strip

16647

132773

1.49

261.72

4.3

3.4

estimate

0.0

0.60

3192

24664

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

280

258

10.83

258.66

1.0

1.1

ug/l

71.0

91.2

8.08

248

204

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2402

11419

2.17

253.86

10.8

9.6

mmol/l

24.7

24.2

8.13

2223

10732

(3021601) Nitrite [Presence] in Urine by Test strip

16462

131544

1.48

252.70

5.8

4.5

estimate

0.0

0.20

3442

25197

(3000850) Epithelial cells [#/volume] in Urine

7530

51448

1.58

239.67

2.9

2.5

e6/l

7.4

6.0

13.38

6569

44796

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

4796

29431

1.72

232.70

5.2

4.1

29.7

32.5

65.27

3753

20589

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

4195

24787

1.78

232.66

1.9

1.7

—

(3028626) Oxygen [Partial pressure] in Capillary blood

1313

4966

2.69

230.87

3.3

3.1

kpa

8.3

8.5

6.29

1235

4604

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

4201

24954

1.77

228.47

1.9

1.7

—

(3044889) 12 lead EKG panel

21084

178779

1.47

226.75

4.3

3.4

—

(3021901) Oxygen saturation in Capillary blood

1092

3784

2.92

226.57

3.2

2.7

—

(3021589) Normoblasts [#/volume] in Blood

14870

118052

1.45

225.97

11.4

8.9

e9/l

0.0

2.61

12258

97094

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

1108

3884

2.89

225.09

1.1

iu/ml

43.2

3094.6

0.67

247

908

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

5470

35047

1.66

224.73

1.9

1.7

1.4

2.85

4790

31198

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

4694

28904

1.71

224.16

2.7

umol/l

7.9

8.0

0.15

3965

24925

(36304419) Bacteria [Presence] in Urine

9292

67338

1.51

223.54

3.5

2.9

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

3134

17192

1.89

220.66

3.1

2.7

ng/l

166.1

171.4

0.33

2771

15596

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2085

9986

2.14

215.08

3.6

2.9

1.4

1.3

6.26

2074

9932

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2642

13805

1.97

214.87

11.0

9.4

0.6

0.7

4.90

2621

13733

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2644

13831

1.97

214.31

10.9

9.2

1.5

1.4

4.10

2621

13751

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2049

9761

2.15

214.29

3.6

2.9

0.7

0.37

1972

9351

(3014007) Fractional oxyhemoglobin in Arterial blood

2647

13899

1.96

212.13

11.1

9.4

93.0

94.2

18.07

2635

13851

(3027945) Reticulocytes/100 erythrocytes in Blood

4067

24439

1.74

211.11

2.5

2.6

2.0

1.7

35.69

3578

21811

(3019225) pH of Specimen

3823

22849

1.74

201.62

4.5

4.0

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

30855

288202

2.09

200.58

13.4

9.5

u/l

30.6

25.9

187.95

30134

279106

(3020564) Creatinine [Moles/volume] in Serum or Plasma

30698

286421

2.02

196.82

22.4

13.9

umol/l

78.4

73.7

57.02

30691

286291

(3037522) Nuclear Ab [Titer] in Serum

5743

38458

1.58

193.48

1.4

titre

483.0

551.1

1.99

1071

7768

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2545

13589

1.93

193.39

8.5

7.0

mmol/l

25.1

24.5

10.77

2399

12635

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2143

10840

2.02

190.28

5.2

4.4

mmol/l

24.2

24.1

1.00

1893

9788

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2994

16976

1.82

188.21

1.7

1.6

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1737

8162

2.17

187.49

2.3

2.0

ug/l

1.9

2.1

0.30

1541

7233

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2591

14112

1.89

185.00

8.4

7.1

mmol/l

25.2

24.7

7.29

2565

14001

(1616796) Gas panel - Central venous blood

1227

5009

2.48

183.81

4.8

3.3

—

(3020891) Body temperature

1794

8615

2.12

183.04

5.7

4.9

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

488

1157

4.22

181.93

1.9

1.5

nmol/l

1.6

1.1

11.53

375

922

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2524

13723

1.89

181.04

1.7

1.5

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1510

6881

2.23

175.69

3.4

3.3

u/ml

0.3

0.4

0.19

872

3876

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2362

12743

1.90

173.22

1.8

1.6

—

(3020630) Protein [Mass/volume] in Serum or Plasma

3017

17778

1.75

165.30

2.0

2.6

g/l

66.7

0.07

2749

16300

(40758558) Short blood count panel - Blood

8807

66185

1.44

165.23

6.8

6.9

—

(3034770) Mitochondria Ab [Titer] in Serum

1516

7101

2.17

164.53

1.2

1.3

titre

958.1

931.4

0.04

220

(4010399)

3036

17948

1.74

164.40

1.5

1.4

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

6083

42695

1.50

161.73

2.7

3.0

mmol/l

2.4

4.80

5202

37459

(3018405) Lactate [Moles/volume] in Arterial blood

1564

7488

2.12

160.38

4.7

4.2

mmol/l

1.4

1.23

1532

7358

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

5961

41793

1.50

158.98

2.9

2.6

e6/l

1.4

1.1

2.24

3394

23392

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

12694

102067

1.38

158.98

4.6

3.5

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

6345

45141

1.49

157.25

4.2

3.4

ng/l

343.5

503.9

2.02

4581

31783

(3007566) Smooth muscle Ab [Titer] in Serum

1510

7213

2.13

155.68

1.2

1.3

titre

120.7

125.7

0.09

139

674

(3007164) IgA [Mass/volume] in Serum or Plasma

7451

54970

1.44

152.21

1.5

1.4

g/l

2.6

2.3

28.13

4554

34199

(3000494) Fungus identified in Specimen by Culture

4514

30059

1.57

151.99

1.5

1.4

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

4034

26221

1.60

150.63

3.5

4.3

u/l

235.4

240.0

1.24

3801

24902

(3028026) IgM [Mass/volume] in Serum or Plasma

2603

15083

1.77

150.55

1.6

1.9

g/l

1.1

1.3

9.70

2373

13839

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

5571

38959

1.50

149.27

3.1

2.8

e6/l

5.1

3.0

7.80

3027

20709

(3023520) Reticulocytes [#/volume] in Blood

2965

17874

1.71

148.85

2.6

e9/l

80.4

69.2

38.80

2221

13365

(3029937) Albumin [Presence] in Urine by Test strip

9132

70143

1.40

147.89

4.8

3.7

estimate

0.0

0.60

3253

24456

(40761511) CBC panel - Blood by Automated count

30359

285417

1.76

143.64

19.0

11.4

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

6361

46140

1.45

140.51

1.3

u/ml

9.4

11.2

1.42

2454

18610

(3010421) pH of Blood

1277

5994

2.15

137.49

5.7

3.5

7.4

7.17

1117

5060

(3005719) IgG [Mass/volume] in Serum or Plasma

3152

19734

1.64

136.29

2.4

2.7

g/l

10.6

10.5

0.58

2877

18115

(3027315) Oxygen [Partial pressure] in Blood

1149

5194

2.23

135.86

5.7

3.6

kpa

8.6

8.8

4.55

1123

5085

(3008037) Lactate [Moles/volume] in Venous blood

1005

4292

2.36

135.86

3.9

2.9

mmol/l

1.6

1.5

2.54

986

4194

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

6637

48818

1.43

135.26

1.3

iu/ml

32.7

33.7

0.11

1835

15383

(3017143) Hepatitis C virus Ab [Presence] in Serum

5027

35055

1.50

135.06

1.7

1.6

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

8347

63929

1.39

134.92

1.3

u/ml

1.5

1.6

0.52

2246

17802

(3013290) Carbon dioxide [Partial pressure] in Blood

1142

5165

2.23

134.85

5.7

3.6

kpa

5.2

5.0

18.17

1116

5057

(3009214) Lutropin [Units/volume] in Serum or Plasma

1706

8964

1.93

134.53

1.4

1.3

u/l

8.6

10.6

9.79

1398

7371

(3012501) Base excess in Blood by calculation

1141

5164

2.23

134.51

5.7

3.6

mmol/l

3.0

2.4

9.08

799

3406

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

6933

51709

1.42

129.95

1.8

1.7

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

2919

18160

1.65

129.03

3.1

3.4

pmol/l

4.5

2.11

2555

16329

(3037121) Protein [Mass/volume] in Urine

1550

7994

1.97

129.01

2.9

3.2

g/l

0.4

0.3

1.99

726

3535

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1116

5099

2.21

128.47

1.4

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

5172

36673

1.47

126.98

2.3

2.2

30.2

29.6

8.68

5011

35591

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1269

6134

2.09

126.42

1.3

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1805

9876

1.86

125.47

1.8

g/l

1.7

1.5

14.46

1549

8509

(3013139) Helicobacter pylori Ag [Presence] in Stool

2882

18000

1.64

125.25

1.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1948

10939

1.81

124.44

2.0

1.6

mg/l

5.1

3.3

8.19

1780

7252

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

3589

23674

1.56

124.01

2.6

2.5

u/l

53.5

44.2

0.28

2967

20403

(3038515) Glucose [Moles/volume] in Venous blood

937

4039

2.34

123.92

4.1

3.0

mmol/l

7.9

7.4

4.89

921

3959

(3004588) Protein electrophoresis panel - Serum or Plasma

2416

14448

1.71

123.91

1.8

2.3

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

3624

23976

1.56

123.55

4.1

3.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1109

5145

2.17

122.84

2.6

2.1

g/l

131.7

130.9

0.44

820

3713

(3043409) Potassium [Moles/volume] in Arterial blood

1313

6496

2.04

122.80

5.1

4.5

mmol/l

3.9

2.45

1221

6133

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

907

3876

2.35

122.35

1.7

1.6

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

3016

19179

1.61

121.69

4.9

3.7

mmol/l

1.2

15.80

2676

16778

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1651

8924

1.88

119.11

5.9

4.9

1.8

1.7

2.48

1574

8323

(3011397) Hemoglobin [Presence] in Urine by Test strip

7889

60915

1.37

118.34

4.1

3.4

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

146

162

8.96

117.91

2.2

1.7

umol/l

1.3

0.37

141

138

(40767503) Oxygen content in Capillary blood by calculation

1030

4755

2.18

115.45

3.2

2.4

16.6

0.20

612

2381

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1858

10585

1.78

112.80

1.5

u/ml

12.1

12.9

0.11

292

(3023183) Ammonium ion [Moles/volume] in Plasma

1023

4785

2.15

110.89

3.4

2.8

umol/l

36.6

33.8

2.61

880

4082

(3007930) Methemoglobin/Hemoglobin.total in Blood

1601

8778

1.85

110.24

6.0

5.0

0.8

0.9

9.21

1529

8195

(3019150) Specific gravity of Urine by Refractometry

7348

56664

1.37

109.63

4.7

3.6

kg/l

1.0

0.10

1095

8492

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

393

1154

3.40

107.72

1.7

1.6

nmol/l

3.0

10.1

0.79

320

959

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2053

12217

1.71

106.66

12.6

9.6

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

488

1644

2.97

106.27

1.3

umol/l

5.5

5.1

1.38

450

1518

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1731

9827

1.79

106.19

2.0

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

742

3096

2.41

105.58

3.1

3.0

nmol/l

0.8

0.06

584

2331

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

2826

18317

1.58

104.37

2.4

2.2

ug/l

5.9

7.7

5.68

2384

16148

(1761482) Bacteria [#/volume] in Urine by Culture

1086

5360

2.04

102.04

4.4

3.7

—

(3011985) Renin [Units/volume] in Plasma

778

3372

2.32

101.51

1.5

1.6

mu/l

79.1

63.8

1.17

687

3028

(3021387) Prolactin [Units/volume] in Serum or Plasma

2017

12174

1.68

99.19

1.7

1.6

mu/l

301.1

312.6

0.77

1801

10962

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1579

8917

1.79

98.45

2.0

1.8

—

(3028717) Thiamine [Mass/volume] in Blood

144

196

7.30

98.22

1.4

1.1

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1498

8409

1.80

95.24

1.6

titre

145.8

319.9

2.79

333

(3035285) Chloride [Moles/volume] in Venous blood

591

2331

2.54

94.95

2.8

2.2

mmol/l

105.7

0.08

586

2310

(3041354) Potassium [Moles/volume] in Venous blood

591

2332

2.54

94.87

2.8

2.2

mmol/l

4.1

4.0

1.12

586

2311

(3017181) Myelocytes/100 leukocytes in Blood

3148

21322

1.51

94.70

4.4

4.1

0.9

0.60

940

5644

(3033705) Calcium.ionized [Moles/volume] in Venous blood

583

2289

2.55

94.56

2.8

2.2

—

(3021440) Promyelocytes/100 leukocytes in Blood

3022

20318

1.52

94.11

4.4

4.2

0.1

0.04

894

5212

(3004775) Volume in Urine collected for unspecified duration

465

1634

2.84

93.81

2.3

739.9

657.4

2.74

317

1155

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

1041

5238

2.00

92.61

1.4

1.3

u/l

17.1

27.1

29.52

846

4331

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1310

7125

1.85

92.28

1.9

1.7

nmol/l

32.5

43.7

46.50

1265

6958

(40761535) Cells panel - Urine sediment

2922

19609

1.52

91.67

4.0

3.4

—

(3041096) Erythrocytes [Presence] in Urine by Automated

9025

73267

1.30

91.22

4.0

3.0

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

7406

58683

1.32

88.84

1.7

1.6

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1397

7844

1.80

88.65

2.4

2.3

ug/l

623.6

505.1

0.28

1306

7266

(3001186) Copper [Moles/volume] in Serum or Plasma

238

566

4.19

88.53

1.8

1.2

umol/l

17.5

16.9

1.02

216

498

(3024928) Oxygen saturation in Venous blood

944

4673

2.03

87.89

4.1

3.5

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1166

6227

1.89

86.93

2.2

3.4

ratio

2.4

3.7

0.47

502

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

703

3128

2.25

86.18

1.3

1.4

pmol/l

300.1

315.6

0.45

579

2414

(3002179) Metamyelocytes/100 leukocytes in Blood

2874

19460

1.51

86.14

3.9

0.6

0.7

0.92

692

4100

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1190

6419

1.87

85.98

2.2

3.5

mg/l

39.2

41.1

0.26

915

5223

(3034860) Kappa light chains.free [Mass/volume] in Serum

1191

6428

1.87

85.90

2.2

3.5

mg/l

55.0

57.9

0.12

923

5225

(3020876) Protein [Mass/time] in 24 hour Urine

483

1817

2.66

85.50

2.0

g/24h

1.3

1.0

0.48

105

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

936

4669

2.01

85.29

1.2

titre

105.3

142.7

0.32

103

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1249

6882

1.83

84.30

2.0

1.7

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

4076

29638

1.41

83.94

8.0

6.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

2637

17633

1.52

83.77

2.8

2.1

nmol/l

8.8

12.3

97.57

2292

15763

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

658

2914

2.26

81.59

7.2

6.3

mg/l

11.3

11.4

0.25

604

2686

(40760892) CBC W Ordered Manual Differential panel - Blood

7738

62278

1.30

81.58

4.9

4.3

—

(3040151) Glucose [Moles/volume] in Capillary blood

589

2491

2.37

81.31

11.4

7.7

mmol/l

8.3

7.1

2.88

486

2028

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1702

10339

1.66

81.25

1.5

1.7

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

2307

15120

1.55

80.22

2.5

2.2

u/l

5233.9

6104.8

0.86

880

6175

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1214

6742

1.81

79.80

1.4

1.5

iu/ml

14.7

0.00

149

(3025159) Blasts/100 leukocytes in Blood

2820

19316

1.49

79.57

4.5

4.2

0.1

0.2

2.61

766

4423

(3000330) Specific gravity of Urine by Test strip

1855

11636

1.61

77.84

3.9

3.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

941

4861

1.94

77.52

2.1

1.8

pmol/l

152.8

191.6

23.39

870

4638

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

601

2619

2.30

77.44

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

715

3345

2.14

77.38

1.2

1.3

u/l

35.7

33.4

0.13

613

2929

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1120

6151

1.83

76.33

1.5

1.4

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

524

2165

2.42

76.23

1.9

2.2

nmol/l

18.8

19.3

0.65

487

2068

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

191

432

4.40

75.90

1.4

nmol/l

5.7

5.6

0.15

181

411

(3005322) IgE [Units/volume] in Serum or Plasma

2691

18449

1.48

75.39

1.3

u/ml

265.6

228.7

0.64

2515

17098

(3000492) Spirometry study

3640

26518

1.40

73.38

1.5

1.4

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

7622

61982

1.28

72.62

2.0

1.9

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1760

11089

1.60

72.39

2.1

2.0

u/l

38.6

39.4

0.92

1558

9975

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1936

12499

1.57

71.73

3.0

2.6

e6/l

0.4

0.3

3.22

1891

12101

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

428

1666

2.56

70.76

13.5

11.9

mmol/l

0.6

0.23

390

1533

(3025941) Bacteria identified in Stool by Culture

2377

16111

1.50

70.26

1.3

1.2

—

(3035637) Corticotropin [Mass/volume] in Plasma

673

3201

2.10

69.78

1.6

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

905

4792

1.89

69.18

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

904

4790

1.89

68.96

1.4

1.3

—

(3028271) Lactate [Moles/volume] in Capillary blood

731

3608

2.03

68.58

2.4

1.8

mmol/l

1.7

0.37

715

3523

(3003694) ABO and Rh group [Type] in Blood

9698

81620

1.25

68.40

1.6

1.5

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1219

7105

1.73

67.72

1.4

ug/g

283.8

280.2

0.24

673

4029

(3000475) Leukocytes [#/volume] in Synovial fluid

1017

5642

1.81

67.00

1.7

1.6

e6/l

14320.4

12448.8

0.57

721

4137

(3016750) Collection duration of Urine

344

1234

2.78

66.89

2.1

2.2

min

498.2

499.7

0.09

246

953

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

823

4309

1.91

65.11

1.9

1.6

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

711

3555

2.00

64.35

1.2

1.3

nmol/l

0.1

0.3

3.14

222

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1144

6651

1.73

64.11

3.5

3.8

mg/l

1.8

1.4

36.85

1040

6181

(40760888) Immunoglobulin light chains.free panel - Serum

894

4845

1.85

63.54

2.2

3.5

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

292

988

2.94

63.27

2.0

2.1

ug/min

184.0

84.8

0.57

217

(21494755) Public health laboratory ask at order entry panel

2404

33331

0.69

63.15

1.4

1.3

—

(3017569) Oxygen content in Arterial blood

272

885

3.06

63.14

2.1

2.2

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

710

3573

1.99

63.09

1.2

1.3

nmol/l

1.1

1.3

0.09

683

3433

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

656

3211

2.04

62.99

1.2

1.3

—

(3052851) Hemolysis interference index of Serum or Plasma

1232

7351

1.69

62.74

3.2

3.0

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

689

3463

1.99

61.45

1.1

g/l

1.5

0.22

609

3164

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1332

8170

1.64

60.94

1.8

2.3

g/l

4.1

3.8

12.74

944

5909

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1334

8191

1.64

60.77

1.8

2.3

g/l

7.8

7.3

21.54

978

6216

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1332

8180

1.64

60.64

1.8

2.3

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1354

8356

1.63

60.44

1.6

1.8

g/l

0.3

0.2

37.86

1287

7926

(3048689) Calprotectin [Mass/mass] in Stool

4605

35804

1.32

60.00

2.3

2.4

ug/g

143.9

124.1

3.21

3644

28086

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

2942

21363

1.40

59.70

1.2

iu/ml

127.8

146.4

1.71

1058

8264

(3022806) Fractional oxyhemoglobin in Capillary blood

605

2963

2.04

58.02

2.3

1.7

89.2

90.2

4.04

594

2920

(3020717) Zinc [Moles/volume] in Serum or Plasma

342

1316

2.59

57.98

1.7

1.4

umol/l

16.1

27.4

14.78

331

1248

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

391

1610

2.42

57.42

12.9

12.8

nmol/l

837.3

837.8

0.01

376

1557

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

405

1697

2.38

57.21

18.7

17.7

nmol/l

3277.7

2001.1

0.31

389

1622

(3028707) Methadone [Presence] in Urine by Screen method

946

5387

1.76

57.01

2.4

2.8

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1373

8642

1.60

56.48

1.6

1.8

g/l

1.3

1.2

81.28

1311

8224

(3017732) Neutrophils [#/volume] in Blood

2619

18817

1.41

56.36

3.1

2.6

e9/l

4.5

4.0

20.06

1993

15014

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1240

7642

1.63

55.62

1.8

2.3

g/l

10.1

10.2

0.12

1059

6436

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

577

2824

2.04

55.45

2.2

2.0

mg/l

24.0

25.3

0.22

183

744

(3021788) Differential panel - Synovial fluid

794

4336

1.83

55.07

1.6

1.5

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

696

3653

1.91

54.67

6.1

5.1

umol/l

358.0

374.4

2.14

614

3178

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

954

5553

1.72

53.19

1.5

1.7

—

(40768441) Liver Pathology biopsy report

411

1795

2.28

52.80

1.4

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

943

5494

1.72

52.41

1.4

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

292

1111

2.62

50.72

2.1

umol/l

151.8

145.0

0.10

152

558

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

555

2768

2.00

50.65

1.4

mmol/l

12.2

11.6

0.72

193

525

(3022145) Colonoscopy Study observation

3788

29328

1.32

50.09

1.3

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

430

1957

2.19

50.01

1.1

mg/l

295.0

291.4

0.43

365

1785

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

843

4823

1.75

49.99

1.6

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1229

7759

1.59

49.86

1.9

2.3

g/l

3.1

3.0

4.13

966

6078

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

2743

20274

1.37

49.53

3.1

2.5

ml/min/173m2

64.7

69.9

6.79

1280

7625

(3044941) Cell count panel - Synovial fluid

670

3608

1.86

48.63

1.5

1.4

—

(3003129) Base excess in Capillary blood by calculation

174

509

3.40

48.25

1.7

mmol/l

0.8

0.5

0.32

166

476

(3019977) pH of Arterial blood

291

1140

2.54

47.64

2.7

2.5

7.4

1.04

115

380

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1370

9004

1.53

46.47

2.1

1.7

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

907

5402

1.68

46.46

1.5

1.7

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1125

7084

1.59

46.13

2.2

2.1

mg/l

11.1

10.6

1.11

1042

6636

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1115

7008

1.60

46.08

2.0

2.4

g/l

0.5

0.8

3.43

968

6076

(3000034) Microalbumin [Mass/volume] in Urine

434

2062

2.10

45.26

3.7

2.8

mg/l

51.3

51.6

0.01

331

1439

(3012565) Volume of 24 hour Urine

297

1205

2.45

45.16

2.3

2.1

1931.1

2019.3

0.75

266

1089

(3020491) Glucose [Moles/volume] in Blood

413

1927

2.14

45.15

2.0

1.7

mmol/l

7.1

6.4

3.56

278

1461

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1254

8145

1.55

44.89

2.5

2.7

g/l

4.0

3.5

22.00

1194

7748

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

688

3831

1.80

44.79

1.3

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

595

3168

1.88

44.78

1.4

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

595

3176

1.87

44.43

1.4

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

594

3174

1.87

44.21

1.4

1.5

—

(3036489) Thrombin time

1499

10144

1.49

44.16

2.0

2.1

21.2

21.3

0.43

1267

8740

(4034850)

1256

8195

1.54

44.04

10.8

8.6

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

608

3285

1.85

43.70

1.4

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

597

3212

1.86

43.49

1.4

1.5

—

(3004809) Band form neutrophils/100 leukocytes in Blood

666

3706

1.80

43.47

2.8

3.2

1.2

1.5

1.28

524

2882

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

401

1879

2.13

43.38

1.1

1.3

u/ml

—

34.1

—

(40761536) Microorganisms panel - Urine sediment

3007

23033

1.32

42.49

4.8

3.6

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1000

6256

1.60

42.14

1.9

2.2

g/l

0.0

4.42

917

5739

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1017

6390

1.59

42.08

1.8

2.2

g/l

36.7

38.2

12.71

884

5544

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

696

3962

1.76

42.04

1.5

1.7

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

591

3208

1.84

41.87

1.4

—

(3007461) Platelets [#/volume] in Blood

31404

305177

1.50

41.35

29.8

18.1

e9/l

263.2

255.9

72.25

30908

298033

(3016650) Hepatitis A virus Ab [Presence] in Serum

761

4473

1.70

40.98

1.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

551

2955

1.86

40.58

1.6

58.7

54.5

1.50

343

1878

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

724

4210

1.72

40.56

1.6

1.3

mmol/l

7.4

6.9

3.73

530

3034

(3035941) MCH [Entitic mass]

31410

305392

1.49

39.63

29.6

18.0

29.8

30.3

307.65

31141

301777

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

20911

194942

1.17

39.15

3.6

3.3

—

(3024731) MCV [Entitic volume]

31410

305435

1.48

39.12

29.6

18.0

90.1

90.7

110.01

31142

301806

(3026361) Erythrocytes [#/volume] in Blood

31411

305459

1.48

38.98

29.7

18.0

e12/l

4.6

4.5

95.53

30855

297585

(3037756) Immunofixation for Serum or Plasma

729

4296

1.70

38.90

1.4

1.8

—

(3022621) pH of Urine by Test strip

2247

16705

1.36

38.73

3.4

2.7

—

(3010813) Leukocytes [#/volume] in Blood

31413

305527

1.48

38.45

29.8

18.1

e9/l

7.4

6.6

307.65

30843

297621

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

439

2224

1.97

38.43

1.6

1.5

29.1

33.5

1.61

275

1383

(3014271) Vancomycin [Susceptibility]

230

894

2.56

38.39

3.1

2.9

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1158

7649

1.52

38.33

1.4

1.3

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

920

5773

1.59

38.28

1.8

2.3

g/l

0.0

0.10

839

5271

(3000963) Hemoglobin [Mass/volume] in Blood

31415

305565

1.48

38.28

29.9

18.1

g/l

134.9

135.6

13.31

31161

301979

(3044242) Glucose [Moles/volume] in Arterial blood

238

945

2.50

38.00

2.2

2.0

—

(3044927) Protein electrophoresis panel - Urine

395

1949

2.02

37.28

1.3

1.2

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1279

8691

1.48

36.85

2.1

2.3

93.6

92.6

0.74

1178

8064

(3011288) Drugs identified in Urine by Screen method

1278

8684

1.48

36.83

2.5

3.0

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

903

5697

1.59

36.73

1.8

2.3

g/l

0.0

0.00

832

5260

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2905

22583

1.30

36.58

1.4

1.5

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

163

548

2.96

35.97

1.2

pmol/l

322.8

336.5

0.12

113

417

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

595

3395

1.75

35.70

2.7

2.6

u/ml

389.3

581.7

0.18

571

3185

(3001556) Androgen free Index in Serum or Plasma

111

295

3.74

35.70

1.3

1.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

661

3888

1.70

35.54

1.3

1.5

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

2318

17533

1.33

35.51

1.4

1.3

iu/l

20.4

28.0

36.10

1930

15222

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

730

4428

1.65

34.91

1.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

147

480

3.04

34.17

1.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

595

3472

1.71

32.98

1.4

—

(40768804) Tissue Pathology biopsy report

12285

110840

1.16

32.98

2.0

—

(3002385) Erythrocyte distribution width [Ratio]

24342

230836

1.17

32.78

23.4

14.8

14.0

13.6

294.36

24012

226258

(3022689) Creatine [Moles/volume] in Urine

179

666

2.67

32.72

1.5

—

(3004451) EKG impression Narrative

231

970

2.37

32.72

1.3

1.2

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1170

8013

1.46

32.38

2.4

2.6

195.8

181.0

6.91

1110

7583

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

676

4111

1.64

32.03

1.5

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

257

1142

2.24

31.91

1.8

1.7

umol/l

1.9

2.0

1.38

245

1068

(3047181) Lactate [Moles/volume] in Blood

1086

7351

1.48

31.91

7.7

5.5

mmol/l

1.4

1.3

3.85

985

6487

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

542

3115

1.74

31.76

1.6

1.5

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

814

5190

1.57

31.67

4.7

3.1

mg/l

24.5

26.3

0.72

537

3188

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1575

11425

1.38

31.56

1.3

u/ml

0.4

1.0

2.69

170

970

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

380

1976

1.91

30.91

1.3

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

380

1976

1.91

30.91

1.3

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

380

1976

1.91

30.91

1.3

1.7

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1252

8769

1.43

30.73

1.7

1.9

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1682

12384

1.36

30.71

2.5

2.3

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

410

2193

1.86

30.58

1.5

1.4

e6/l

107735.8

100471.9

0.08

302

1499

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

519

2981

1.74

30.50

1.4

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

472

2638

1.78

30.49

1.2

u/l

58.6

62.6

0.61

323

1766

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

216

911

2.36

30.34

2.5

2.4

—

(36660697) Celiac disease serology panel - Serum

2884

22929

1.27

30.14

1.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

2324

29151

0.77

29.90

1.8

1.7

—

(40768443) Skin Pathology biopsy report

1532

11187

1.37

29.45

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

1145

7962

1.44

29.24

1.2

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

301

1474

2.03

29.14

1.4

1.5

u/ml

19.1

24.6

1.23

283

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1134

7886

1.44

28.95

1.2

—

(4306422)

697

4380

1.59

28.90

1.2

—

(3006270) Folate [Moles/volume] in Blood

370

1953

1.89

28.79

1.2

1.1

nmol/l

379.1

0.00

290

1733

(42529406) Shigella sp [Presence] in Stool by Culture

1144

7977

1.44

28.78

1.2

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

444

2483

1.78

28.66

2.7

3.6

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

291

1418

2.04

28.57

1.3

1.4

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

693

4364

1.58

28.49

1.1

—

(3002256) Pathology report gross observation

4150

34545

1.22

28.39

1.2

1.3

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

627

3860

1.62

28.33

1.3

1.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

286

1396

2.04

27.96

1.3

1.4

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

244

1123

2.16

27.85

1.5

1.4

mu/l

434.1

708.5

1.77

232

1071

(3036603) Volume of Urine

321

1638

1.95

27.67

1.6

1.7

1964.1

1980.0

0.05

347

(3048929) Epstein Barr virus Ab [Presence] in Serum

1326

9558

1.39

27.59

1.2

1.3

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

1368

9913

1.38

27.57

2.1

2.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1063

7383

1.44

27.33

2.5

2.6

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1505

19799

0.74

27.33

1.4

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

392

2149

1.82

27.07

1.2

titre

146.4

179.3

0.41

374

(37021550) Renin [Units/volume] in Plasma --upright

138

497

2.76

26.97

1.3

mu/l

99.2

78.2

0.38

100

382

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

389

2144

1.81

26.41

1.2

titre

212.0

160.7

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

245

1155

2.11

26.32

1.5

1.4

72.8

73.0

0.08

233

1103

(3018851) Theophylline [Moles/volume] in Serum or Plasma

155

4.29

26.14

1.7

1.9

umol/l

44.9

44.6

0.03

155

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

232

1075

2.15

26.07

1.3

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

232

1076

2.14

26.01

1.3

1.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

529

3195

1.65

25.84

1.5

1.4

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

321

1684

1.90

25.52

1.6

1.4

mmol/l

5.6

5.5

1.26

301

1598

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1301

9471

1.38

25.49

1.4

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

685

4429

1.54

25.12

1.3

1.2

u/ml

4.5

3.9

0.52

283

1970

(40757494) Bilirubin.total [Moles/volume] in Blood

248

1207

2.04

24.51

2.2

2.1

umol/l

17.9

27.8

0.90

106

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1535

11542

1.33

24.35

1.1

u/ml

1.5

12.2

1.99

171

(3045424) Erythrocytes [Presence] in Urine

688

4485

1.53

24.32

1.5

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

101

325

3.08

24.23

14.4

9.2

mmol/l

5.5

5.4

0.16

101

325

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

163

673

2.41

24.13

2.3

1.8

e6/l

6963.3

11194.8

0.54

355

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

656

4240

1.54

24.12

1.1

125.5

117.7

7.17

584

3839

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

698

4574

1.52

24.08

1.3

1.2

u/ml

3.8

3.5

0.15

215

1575

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

4427

37614

1.19

23.99

2.1

2.0

—

(21494890) Protein electrophoresis panel - 24 hour Urine

383

2185

1.74

23.19

1.5

2.2

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

320

1732

1.84

23.13

1.6

1.5

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

177

774

2.27

23.01

2.3

1.9

e6/l

3297.6

2768.7

0.07

120

525

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

262

1332

1.96

22.94

1.1

u/ml

6.8

10.6

1.08

243

(3023419) Bacteria identified in Sputum by Culture

465

2809

1.65

22.77

2.5

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

136

532

2.54

22.64

1.5

1.4

g/l

13.3

0.04

111

393

(3017315) Amylase [Enzymatic activity/volume] in Urine

268

1381

1.93

22.56

1.4

1.2

u/l

278.9

327.4

0.39

253

1282

(3045414) Leukocytes [Presence] in Urine

1565

11930

1.31

22.53

1.8

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

668

4403

1.51

22.45

1.4

1.6

g/l

0.7

0.94

509

3345

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

109

384

2.82

22.30

3.1

2.3

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

845

5844

1.44

22.28

1.5

1.4

u/ml

13.0

20.3

1.93

115

(3002331) Protein [Mass/volume] in Peritoneal fluid

121

452

2.66

22.13

1.5

1.4

g/l

26.7

28.7

0.24

345

(3033799) Differential panel - Peritoneal fluid

157

666

2.34

21.93

2.4

1.9

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

126

483

2.59

21.89

1.3

1.5

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

373

2148

1.73

21.87

3.2

2.8

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

432

2592

1.66

21.74

1.6

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1161

8517

1.36

21.70

1.7

1.6

iu/ml

1.7

6.4

0.89

249

1716

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

917

6470

1.42

21.66

1.2

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

845

5884

1.43

21.49

1.5

1.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

380

2218

1.70

21.24

1.1

—

(3039000) Anion gap in Blood

749

5117

1.46

21.10

8.9

6.5

mmol/l

11.4

11.2

1.11

686

4601

(3018572) Chloride [Moles/volume] in Blood

749

5118

1.46

21.07

8.9

6.5

mmol/l

105.2

105.3

0.28

686

4602

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

485

3021

1.60

21.01

1.8

1.6

mmol/l

8.5

7.4

14.60

302

1799

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

163

716

2.26

21.01

1.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

4836

41880

1.17

20.55

2.1

—

(44806420)

125

494

2.51

20.42

2.2

2.3

—

(3045716) Anion gap in Serum or Plasma

201

971

2.06

20.38

2.8

2.5

mmol/l

9.0

9.2

0.35

158

697

(3008898) HLA-B27 [Presence]

1416

10803

1.31

20.27

1.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

273

1472

1.84

20.05

1.2

1.3

u/l

79.8

88.6

1.07

241

1282

(3032057) Clostridioides difficile [Presence] in Stool

118

458

2.56

20.03

2.0

1.8

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

184

868

2.11

19.88

1.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1939

15437

1.26

19.81

1.4

—

(4062490)

453

2817

1.60

19.80

1.5

1.4

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

386

2308

1.66

19.74

2.7

3.3

60.4

58.1

1.15

253

1503

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

246

1292

1.89

19.63

1.2

1.3

titre

58.8

77.0

0.46

110

(3004616) Nuclear Ab [Presence] in Serum

520

3346

1.55

19.60

1.3

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1945

15520

1.26

19.49

2.7

3.1

u/ml

38.7

48.1

1.45

1862

15012

(3027135) IgG subclass 1 [Mass/volume] in Serum

451

2813

1.60

19.47

1.4

g/l

6.3

6.8

2.70

318

1983

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

352

2062

1.70

19.46

1.3

1.2

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

182

865

2.09

19.30

1.5

1.4

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

193

938

2.04

19.28

1.3

1.4

pmol/l

13.3

14.8

3.29

160

792

(3034274) Bile acid [Moles/volume] in Serum --fasting

715

4929

1.45

19.24

2.1

umol/l

5.5

6.4

1.07

519

3584

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

265

1435

1.84

19.22

1.2

1.3

u/l

20.3

22.7

0.57

226

1235

(3006576) Bicarbonate [Moles/volume] in Blood

168

776

2.15

19.19

6.9

6.2

mmol/l

25.8

24.9

1.38

152

711

(3024139) IgG subclass 3 [Mass/volume] in Serum

449

2810

1.59

19.12

1.4

g/l

0.4

0.01

319

1987

(3028192) IgG subclass 2 [Mass/volume] in Serum

449

2810

1.59

19.12

1.4

g/l

2.8

3.0

0.91

320

1983

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

110

423

2.58

19.06

3.5

2.1

mmol/l

7.8

7.4

0.49

253

(3016879) Cocaine [Presence] in Urine

1531

11907

1.29

18.95

2.1

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

249

1329

1.86

18.92

1.2

1.3

titre

595.9

396.7

0.27

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

6.40

18.91

4.9

5.6

mmol/l

0.2

0.3

0.50

(3000764) Benzodiazepines [Presence] in Urine

1637

12856

1.27

18.75

2.0

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

232

3.16

18.66

1.6

1.5

ug/l

110.6

112.8

0.06

194

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

773

5440

1.42

18.59

1.5

u/ml

107.2

112.9

0.94

189

1213

(3051101) Glucose [Moles/volume] in Cord blood

334

2.76

18.44

5.8

5.6

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

382

2320

1.64

18.42

1.4

1.8

—

(3000093) Morphology [Interpretation] in Blood Narrative

365

2192

1.66

18.40

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

287

1615

1.77

18.35

1.2

1.4

—

(3049717) Cytology report of Urine Cyto stain

1062

7891

1.34

18.30

2.3

2.6

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1931

15505

1.25

18.30

1.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

970

7121

1.36

18.09

1.2

1.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

145

649

2.22

17.95

3.4

2.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

145

649

2.22

17.95

3.4

2.4

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

238

3.08

17.89

8.5

7.1

—

(3042631) Mycobacterium sp identified in Specimen

457

2918

1.56

17.88

2.3

2.6

—

(3027008) Opiates [Presence] in Urine

1637

12942

1.27

17.74

2.0

—

(3028300) Cannabinoids [Presence] in Urine

1639

12976

1.26

17.56

2.0

2.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

408

2552

1.59

17.47

1.4

1.7

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

219

1153

1.89

17.42

1.5

5.4

3.6

0.80

268

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

817

5881

1.39

17.25

1.2

u/ml

4.8

5.6

0.13

452

(44806118)

427

2708

1.57

17.24

1.5

1.6

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

817

5882

1.39

17.23

1.2

1.3

—

(44790048)

427

2709

1.57

17.21

1.5

1.6

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

325

1930

1.67

17.14

1.1

—

(44790049)

426

2708

1.57

17.03

1.5

1.6

—

(44790047)

426

2709

1.56

17.00

1.5

1.6

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

805

5803

1.38

16.86

1.2

u/ml

13.8

14.9

0.04

(3037556) Urate [Mass/volume] in Serum or Plasma

140

636

2.18

16.75

1.4

1.3

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

769

5529

1.39

16.37

1.3

u/ml

281.7

264.7

0.92

472

3636

(3035320) C reactive protein [Mass/volume] in Body fluid

315

1884

1.66

16.20

3.2

2.3

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

471

3099

1.51

16.12

1.2

1.1

98.2

94.7

2.00

442

2905

(40762365) Oxygen content in Arterial blood by calculation

347

2.60

16.12

3.4

2.8

ml/dl

14.9

0.01

322

(3013166) Neutrophils/100 leukocytes in Synovial fluid

149

705

2.10

16.09

1.5

1.4

54.1

52.2

0.24

131

601

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

982

7357

1.33

16.04

1.3

u/ml

5.0

9.1

2.61

129

1170

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

283

1650

1.70

16.03

1.2

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

111

469

2.35

15.80

1.3

1.7

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

332

2028

1.63

15.73

1.4

1.6

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

184

948

1.93

15.68

1.9

2.5

ug/l

0.7

1.2

4.88

166

904

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1055

8013

1.31

15.66

1.3

u/ml

30.8

36.2

0.21

507

(3051593) INR in Capillary blood by Coagulation assay

175

887

1.96

15.65

13.3

9.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

221

1209

1.82

15.62

1.4

2.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

221

1209

1.82

15.62

1.4

2.0

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

221

1209

1.82

15.62

1.4

2.0

—

(3038026) Centromere Ab [Units/volume] in Serum

346

2143

1.61

15.50

1.2

u/ml

48.4

47.3

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

222

1224

1.80

15.31

1.2

1.1

iu/ml

3.6

0.02

(3051611) Lipemic interference index of Serum or Plasma

389

2484

1.56

15.30

3.5

3.3

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

471

3134

1.50

15.30

1.2

1.1

iu/ml

1.1

2.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

269

4399

0.60

15.26

1.6

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

818

6010

1.36

15.24

1.2

1.3

mmol/l

4.0

3.7

14.45

762

5639

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

220

1212

1.80

15.21

1.4

2.0

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

306

1853

1.64

15.04

1.1

ratio

1.1

0.08

677

(3044007) Cell count panel - Peritoneal fluid

133

619

2.13

15.03

2.5

1.8

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1681

13597

1.24

14.90

1.6

1.4

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

931

7003

1.33

14.82

1.4

pmol/l

132.7

118.4

0.48

898

6837

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

959

7245

1.32

14.81

1.3

u/ml

7.0

6.0

0.16

766

(3027944) Amphetamines [Presence] in Urine

1585

12748

1.24

14.80

1.9

2.0

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

680

9180

0.73

14.63

1.5

1.4

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

335

2089

1.59

14.62

1.2

u/ml

77.0

68.5

0.17

102

(3024263) Appearance of Synovial fluid

218

1213

1.78

14.61

1.8

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

313

1924

1.62

14.51

1.2

1.1

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

335

2095

1.59

14.46

1.2

u/ml

68.7

43.7

0.74

163

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

184

976

1.87

14.40

1.0

—

(3003181) Sodium [Moles/volume] in Urine

531

3672

1.44

14.19

1.3

1.4

mmol/l

62.4

64.3

0.43

390

2912

(3043238) Trisomy 21 risk [Likelihood] in Fetus

702

9385

0.74

14.19

1.6

1.5

—

(3005033) Fetal Nuchal fold Thickness US

684

9159

0.73

13.97

1.5

1.4

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

217

1223

1.76

13.95

2.0

2.3

ug/l

21.9

177.6

1.82

206

1165

(3042733) HLA Ab [Presence] in Serum

176

932

1.87

13.87

5.0

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

279

1689

1.64

13.78

2.2

2.1

99.9

98.4

0.30

259

1556

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

193

1055

1.82

13.75

3.0

3.1

—

(4024509)

352

2256

1.55

13.68

1.7

1.5

—

(3051651) Icteric interference index of Serum or Plasma

246

1444

1.69

13.68

3.8

3.7

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

320

2008

1.58

13.64

1.2

u/ml

6.6

10.4

0.46

150

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1292

10259

1.26

13.54

1.8

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

234

1364

1.70

13.36

1.6

1.4

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

418

2.30

13.28

2.0

2.7

mg/l

106.3

32.6

1.36

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

900

6847

1.31

13.26

1.3

mg/l

532.5

513.5

0.22

855

6531

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

288

1775

1.61

13.26

1.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

343

2202

1.55

13.25

1.6

1.5

promille

1.3

1.4

0.97

260

1674

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

289

1785

1.61

13.19

1.1

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

730

5394

1.35

13.17

5.3

6.0

iu/ml

7312.4

1306.5

0.43

808

(3027570) Oxalate [Moles/time] in 24 hour Urine

154

3.22

13.10

2.1

1.3

umol/24h

356.9

311.9

0.73

154

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

224

1301

1.71

12.98

1.1

u/l

19.9

24.2

0.74

176

1011

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

185

1019

1.80

12.89

3.0

2.8

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

259

1567

1.64

12.86

1.2

1.5

ug/l

6.4

8.0

1.96

232

1413

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

261

1586

1.63

12.74

1.6

u/l

6.7

6.4

0.06

127

770

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

228

1338

1.69

12.73

1.1

99.9

96.4

0.91

169

1072

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

297

1863

1.58

12.72

2.1

1.9

u/field

2.3

2.1

0.29

131

863

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

223

1302

1.70

12.69

1.1

u/l

81.4

83.9

0.25

186

1047

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

253

1530

1.64

12.60

1.0

1.1

nmol/l

2.5

5.6

1.04

292

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

373

2.34

12.54

4.1

5.2

ug/min

66.4

40.2

1.92

282

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

264

1622

1.62

12.35

1.5

1.9

—

(44813793)

327

2112

1.54

12.33

1.1

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

182

1013

1.78

12.28

6.4

5.1

mg/l

2144.7

2926.9

0.20

129

753

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

106

492

2.14

12.16

3.0

2.4

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

570

4109

1.38

12.08

2.3

3.0

u/ml

500.9

7828.0

1.40

226

(3025315) Body weight

200

2.83

11.96

5.6

4.0

—

(3009542) Hematocrit [Volume Fraction] of Blood

26371

255726

1.11

11.91

20.5

13.1

39.8

39.9

1.61

18691

196481

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

966

7529

1.28

11.87

1.5

1.4

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

943

11801

0.79

11.73

1.5

1.4

—

(3010838) Calcium [Moles/time] in 24 hour Urine

208

1222

1.69

11.62

1.6

mmol/24h

6.2

5.4

0.25

111

(3020961) Endomysium IgA Ab [Titer] in Serum

1715

14254

1.20

11.61

1.1

titre

161.2

212.0

0.28

360

(3019832) Treponema pallidum Ab [Presence] in Serum

4140

36833

1.13

11.40

1.7

—

(3003327) Ova and parasites identified in Stool by Light microscopy

1240

10014

1.24

11.22

1.7

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

932

7302

1.27

11.01

1.9

iu/l

3.6

20.6

1.43

332

2812

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1055

8388

1.25

11.00

1.4

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

216

2.66

10.91

1.1

—

(1761868) Lipid panel - Serum or Plasma

10994

102969

1.09

10.77

3.4

2.5

—

(3026389) Candida sp identified in Specimen by Organism specific culture

563

4129

1.36

10.76

1.4

1.3

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

183

1062

1.71

10.74

1.1

1.2

g/l

0.3

2.80

147

839

(3027035) Albumin [Mass/time] in 24 hour Urine

219

2.63

10.63

1.4

1.3

mg/24h

857.9

226.4

—

(40768446) Kidney Pathology biopsy report

181

1051

1.71

10.60

1.6

1.7

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

203

1221

1.65

10.43

1.7

1.5

—

(3044290) Cell count panel - Cerebral spinal fluid

740

5673

1.30

10.40

1.3

1.4

—

(4015189)

113

571

1.96

10.38

2.5

2.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

168

964

1.73

10.29

1.5

2.2

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

277

2.40

10.19

3.1

2.5

mmol/l

1.1

1.2

0.05

195

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

170

983

1.72

10.14

1.2

111.1

110.8

0.06

150

883

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

185

2.73

10.12

2.9

2.2

69.6

57.5

1.46

111

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

638

4812

1.32

10.12

1.5

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

4.84

10.09

1.1

nmol/24h

92.2

103.0

0.32

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

165

948

1.73

10.07

1.4

2.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

247

1575

1.56

9.98

1.2

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

125

663

1.87

9.96

1.5

1.2

nmol/l

83.4

132.6

3.76

498

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

292

1933

1.50

9.93

1.3

1.2

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

780

6061

1.28

9.90

1.4

1.5

e6/l

1103.0

2472.7

0.99

638

4909

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

290

1920

1.50

9.86

1.3

1.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

164

948

1.72

9.81

1.4

2.2

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

101

501

2.00

9.81

1.2

mg/l

18.0

61.9

0.98

371

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

311

2091

1.48

9.80

1.2

1.3

u/ml

0.7

1.1

0.50

142

884

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

778

6055

1.28

9.75

1.3

1.4

e6/l

67.0

23.4

1.06

603

4668

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

166

965

1.71

9.73

3.4

4.0

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

253

2.43

9.72

1.1

1.0

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

159

915

1.72

9.67

2.7

2.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

202

1238

1.62

9.67

1.7

1.5

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

254

2.42

9.64

1.0

—

(4268621)

426

3050

1.39

9.52

2.4

2.3

—

(4198724)

217

1362

1.58

9.42

1.9

2.3

—

(3003434) Protein [Mass/volume] in Pleural fluid

363

2539

1.42

9.30

1.5

1.4

g/l

33.4

33.8

0.19

335

2308

(40768800) Prostate Pathology biopsy report

282

4067

0.68

9.12

1.2

—

(3023420) DNA double strand Ab [Units/volume] in Serum

433

3140

1.37

8.98

1.5

1.6

iu/ml

32.3

33.6

0.07

155

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

411

2.05

8.90

5.9

5.7

64.1

70.1

1.14

321

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

386

2.08

8.82

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

235

2.40

8.78

2.0

2.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

957

7730

1.23

8.73

1.2

—

(3043410) Blood group antigens tested for on Red Blood Cells

122

671

1.80

8.72

1.7

1.6

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

144

2.82

8.69

2.9

2.3

13.7

17.5

0.42

(3024932) HLA-DR beta [Type]

156

923

1.68

8.63

1.0

1.1

—

(4211845)

214

1369

1.55

8.60

3.4

2.7

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

145

2.80

8.59

1.2

ug/l

134.7

106.9

0.58

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

316

2195

1.43

8.47

1.8

1.7

—

(3008402) Methanol [Moles/volume] in Serum or Plasma

265

2.28

8.37

1.1

1.3

mmol/l

—

1.0

—

(3006462) Nitrate [Presence] in Urine

197

1250

1.56

8.23

3.6

2.8

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1376

11575

1.18

8.23

1.4

1.5

—

(40768793) Breast Pathology biopsy report

506

6537

0.76

8.22

1.3

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

371

2.06

8.18

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

539

4107

1.30

8.05

1.2

—

(3041806) Other cells [#/volume] in Blood by Manual count

1387

0.50

8.03

1.6

1.5

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

343

2442

1.40

8.02

1.4

1.6

—

(3024471) HLA-A [Type]

157

950

1.64

8.00

1.0

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

2218

19389

1.14

8.00

2.3

au/ml

22.2

23.3

0.16

1307

(4281824)

395

2881

1.36

7.97

1.2

1.1

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

2044

17780

1.15

7.93

1.3

au/ml

33.6

47.7

1.67

755

(3000012) Reticulocyte production index

186

1177

1.57

7.89

1.3

1.4

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

103

557

1.83

7.83

1.4

1.6

ug/l

0.4

0.64

379

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

5191

55406

0.91

7.83

1.5

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

142

2.72

7.77

1.6

1.7

0.7

0.05

106

(3019897) Erythrocyte distribution width [Ratio] by Automated count

352

4749

0.73

7.76

3.5

2.4

13.5

13.1

8.69

347

4693

(3001729) Color of Synovial fluid

171

2.55

7.72

1.6

—

(3036670) Protein [Mass/volume] in Synovial fluid

118

668

1.75

7.71

1.4

1.2

g/l

37.0

40.1

1.45

352

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1293

10889

1.18

7.65

1.4

1.3

miu/ml

186.4

226.3

4.01

530

5288

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1207

10108

1.19

7.63

1.5

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

332

4503

0.73

7.59

3.1

3.6

u/ml

25.3

36.1

1.37

314

4333

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

554

4273

1.29

7.57

1.1

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

145

873

1.65

7.57

1.1

u/ml

2.6

6.6

0.50

496

(3023199) Leukocytes [#/volume] in Pleural fluid

324

2309

1.39

7.56

1.6

1.5

e6/l

3163.6

3639.9

0.14

244

1666

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

298

2094

1.41

7.55

3.3

3.8

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

221

1467

1.50

7.55

1.2

u/ml

42.0

10.7

—

164

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

372

2.00

7.40

1.4

1.3

—

(3008295) Osmolality of Serum or Plasma

322

2302

1.39

7.39

1.5

mosm/kgh2o

284.2

279.9

2.51

243

1811

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

207

1363

1.51

7.36

1.3

1.6

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

519

1.83

7.34

1.1

umol/24h

0.9

0.8

0.21

260

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

167

1051

1.58

7.29

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

211

1398

1.50

7.29

1.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

271

1885

1.43

7.28

1.1

iu/ml

7.9

8.5

0.22

491

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

127

749

1.68

7.20

1.6

ug/l

10.9

8.8

4.36

127

749

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

246

1689

1.45

7.11

2.8

3.3

nmol/l

103.1

127.9

1.08

241

1659

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

2341

20698

1.13

7.09

1.5

—

(3016018) Differential panel - Cerebral spinal fluid

399

2971

1.33

7.08

1.3

1.5

—

(3010375) cycloSPORINE [Mass/volume] in Blood

182

1184

1.53

6.89

28.2

28.4

ug/l

116.7

119.1

0.16

149

986

(3003888) Timothy IgE Ab [Units/volume] in Serum

713

5736

1.24

6.86

1.1

u/ml

3.9

5.3

2.50

385

2900

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

129

2.69

6.85

1.0

u/ml

0.3

0.1

0.69

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

244

2.19

6.83

1.0

1.2

mg/l

39.0

46.2

1.76

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

283

2.10

6.81

2.0

—

(44806071)

378

1.94

6.76

1.1

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

249

1731

1.43

6.75

1.3

u/l

448.6

524.4

0.53

234

1650

(3008401) Mugwort IgE Ab [Units/volume] in Serum

680

5453

1.24

6.75

1.1

u/ml

0.7

1.2

1.29

297

2280

(3047189) Immunofixation for 24 hour Urine

153

963

1.58

6.72

1.5

1.9

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

318

2307

1.37

6.72

1.3

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

449

1.85

6.70

1.5

1.4

25.4

23.9

0.17

376

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

114

667

1.69

6.69

1.2

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

204

1368

1.48

6.69

1.7

u/field

2.5

2.4

0.05

142

991

(3035880) pH of Pleural fluid

160

1022

1.55

6.60

1.2

1.3

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

752

6117

1.22

6.53

1.2

u/ml

33.9

43.0

0.80

607

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

263

1863

1.40

6.44

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

548

4315

1.26

6.41

1.1

—

(3042301) Urate [Moles/volume] in Synovial fluid

4.28

6.39

1.0

umol/l

502.3

341.0

—

(3023383) Lactate [Moles/volume] in Pleural fluid

565

1.74

6.38

1.4

1.3

mmol/l

3.6

0.01

520

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1008

8450

1.19

6.37

1.1

u/ml

3.6

5.6

1.60

115

1216

(4094501)

830

6836

1.21

6.37

1.1

—

(40762814) Titanium [Mass/volume] in Blood

346

1.95

6.31

2.2

2.3

ug/l

3.7

4.0

0.22

121

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

780

6404

1.21

6.19

1.1

u/ml

1.2

1.7

1.29

351

2517

(3025886) Oxalate [Mass/time] in 24 hour Urine

3.30

6.15

1.4

1.2

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

427

1.83

6.12

1.2

1.1

u/ml

0.3

0.4

0.04

253

(3016038) Potassium [Moles/volume] in Urine

205

1405

1.45

6.06

1.1

1.3

mmol/l

31.3

34.5

1.48

168

1221

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

210

1447

1.44

6.03

1.1

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

288

2099

1.36

5.97

1.1

1.3

mmol/l

2.1

2.0

0.64

267

1957

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

145

2.46

5.95

1.1

—

(3002619) Bacteria identified in Specimen by Culture

517

1.73

5.71

1.3

1.2

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

205

2.18

5.64

1.4

1.3

ml/s/173m2

1.0

1.7

0.78

138

(3028308) Erythrocytes [#/volume] in Pleural fluid

286

2105

1.35

5.60

1.6

1.5

e6/l

77241.4

50336.2

0.77

170

1253

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

7055

66292

1.07

5.57

4.4

4.7

ug/l

2.2

2.8

1.68

6207

60093

(3017704) Immunofixation for Urine

172

1164

1.47

5.48

1.2

1.7

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

2.90

5.45

1.9

2.1

—

(3014051) Protein [Presence] in Urine by Test strip

711

5866

1.20

5.43

2.1

2.0

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

2.70

5.40

1.1

1.4

nmol/l

558.2

494.7

0.22

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

368

2824

1.29

5.38

1.2

1.1

—

(3026250) Tacrolimus [Mass/volume] in Blood

180

1234

1.45

5.37

36.0

36.1

ug/l

7.3

7.4

0.14

160

1127

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

147

968

1.51

5.37

1.1

1.0

u/ml

5.9

11.2

1.83

129

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

589

1.65

5.30

7.8

9.0

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

167

2.25

5.22

1.5

1.2

mmol/l

24.4

21.5

2.34

123

(3006442) Creatine [Moles/volume] in Serum or Plasma

254

1859

1.36

5.19

1.7

1.5

umol/l

64.4

70.2

1.29

156

(3039162) Centromere protein B Ab [Units/volume] in Serum

458

3628

1.25

5.19

1.3

1.2

u/ml

38.4

51.4

0.53

256

(3000919) Neutrophils/100 leukocytes in Pleural fluid

503

1.69

5.16

1.3

26.5

22.6

0.58

459

(3029634) Reagin Ab [Titer] in Serum by VDRL

513

4121

1.24

5.13

1.8

2.0

titre

2.5

7.8

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

205

1453

1.40

5.11

1.7

1.9

152.8

135.8

2.57

194

1367

(3026470) Cobalt [Mass/volume] in Blood

181

1255

1.43

5.11

2.0

ug/l

4.7

3.3

1.09

153

1116

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

152

1022

1.47

5.04

1.1

96.9

91.7

1.33

461

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

264

1960

1.34

4.94

1.3

1.4

umol/l

13.1

11.5

2.97

243

1871

(3036180) Methadone [Presence] in Urine

3.37

4.93

1.9

2.1

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

234

1706

1.36

4.93

1.9

1.7

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

601

1.62

4.92

1.3

35.8

40.8

0.54

407

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

160

1096

1.45

4.84

1.2

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

117

2.46

4.83

1.0

u/ml

0.1

0.34

(3028433) Virus identified in Specimen by Culture

131

864

1.50

4.80

1.2

1.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

970

8309

1.16

4.80

2.9

3.6

u/ml

1145.6

2108.7

0.44

809

7125

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

452

3616

1.24

4.73

2.3

2.5

—

(21491868) Cryoglobulin [Mass/volume] in Serum

138

924

1.48

4.71

1.2

g/l

0.1

0.6

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

519

4216

1.22

4.70

1.1

1.2

—

(3042517) Benzodiazepines panel - Urine

369

1.77

4.68

3.0

2.8

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

220

1603

1.36

4.68

1.6

1.4

u/l

6.3

5.9

0.26

194

1340

(3025577) Chromium [Mass/volume] in Blood

175

1229

1.41

4.64

2.0

2.1

ug/l

2.4

2.3

0.09

140

1032

(40761539) Cells [Type] in Urine sediment by Light microscopy

611

1.59

4.63

1.3

1.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

533

4357

1.21

4.55

1.2

—

(3018133) Calcium [Moles/volume] in Urine

410

1.72

4.52

2.1

1.9

mmol/l

3.0

2.6

0.65

370

(3023410) Appearance of Cerebral spinal fluid

358

2805

1.27

4.52

1.4

1.6

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

331

1.80

4.47

2.4

2.6

pmol/l

78.5

60.7

0.42

280

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

987

11183

0.87

4.41

1.4

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

359

2824

1.26

4.39

3.1

3.3

nmol/l

5.3

8.0

0.68

334

2735

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

663

5551

1.19

4.39

1.5

1.4

nmol/l

0.4

1.05

528

4368

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

988

11189

0.87

4.39

1.4

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

429

1.69

4.37

1.2

1.3

titre

21.7

172.8

—

(3025130) Human papilloma virus identified in Specimen

421

5122

0.81

4.34

1.6

1.7

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

983

11127

0.87

4.34

1.4

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

506

1.63

4.32

1.3

1.2

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

987

11161

0.87

4.30

1.4

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

2.59

4.29

1.0

—

(3036782) Glucose [Moles/volume] in Pleural fluid

250

1884

1.32

4.28

1.3

mmol/l

6.9

6.2

3.06

229

1741

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

632

1.55

4.26

1.5

1.9

u/l

36.1

34.3

0.04

566

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

141

971

1.44

4.21

2.6

2.4

nmol/l

142.2

152.8

0.70

123

852

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

5081

53095

0.94

4.19

3.9

4.0

22.5

21.7

2.44

2032

24743

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

155

1088

1.41

4.17

2.5

2.4

umol/l

55.9

52.6

0.53

122

912

(3046904) Somatotropin [Units/volume] in Serum or Plasma

3.11

4.13

1.9

2.2

mu/l

2.5

2.3

0.08

(3011436) Histone Ab [Units/volume] in Serum

560

1.58

4.10

1.1

u/ml

—

36.9

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

149

1043

1.42

4.08

1.1

1.2

119.9

109.5

2.55

138

938

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

2.88

4.08

1.9

1.5

nmol/l

153.9

342.4

—

(1175426) CD3 cells/100 lymphocytes in Blood

275

2116

1.29

4.06

1.7

2.1

74.0

73.4

0.29

269

2028

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

103

672

1.52

4.04

1.1

—

(3029612) Listeria sp Ab [Titer] in Serum

2.77

4.03

1.2

1.4

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

102

665

1.52

4.02

1.3

1.4

60.6

61.4

0.08

551

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

188

1373

1.36

4.01

1.3

u/l

13.0

14.6

0.59

174

1273

(3051339) Copper [Moles/volume] in Blood

141

2.18

4.00

1.4

1.3

umol/l

17.5

16.5

0.48

123

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

542

1.57

3.95

1.3

1.1

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

559

1.56

3.91

1.3

1.4

1.5

2.9

1.59

473

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

474

1.61

3.90

1.2

1.4

nmol/l

0.2

0.3

0.66

340

(3041918) Cholesterol [Moles/volume] in Pleural fluid

361

1.70

3.89

1.2

mmol/l

1.5

1.8

0.80

218

(3011412) CD3 cells [#/volume] in Blood

336

2665

1.25

3.89

2.1

2.4

e9/l

1.3

1.2

1.28

193

1592

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

414

3362

1.22

3.85

1.2

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

137

2.17

3.85

1.1

1.3

—

303.3

—

(3045788) Cell count panel - Pleural fluid

235

1786

1.31

3.83

1.6

1.5

—

(3012441) Differential panel - Pleural fluid

259

1994

1.29

3.83

1.6

1.5

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

254

1951

1.29

3.83

2.2

2.6

e6/l

537.5

504.7

0.61

216

1626

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

654

5541

1.17

3.82

1.7

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

269

2083

1.28

3.81

1.7

2.1

13.3

13.9

0.32

130

1017

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

142

1002

1.41

3.76

1.1

100.8

93.2

1.45

458

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

2615

24039

1.08

3.74

3.3

4.1

ug/l

28.1

23.7

0.30

2078

18884

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

126

871

1.43

3.74

1.2

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

107

2.31

3.73

1.0

—

(37019676) Renin [Units/volume] in Plasma --supine

3.03

3.73

1.0

1.1

mu/l

103.4

67.9

—

(3048879) Bone marrow aspiration report

615

1.52

3.68

1.3

2.0

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

246

1896

1.29

3.63

2.2

2.6

e9/l

0.2

0.59

216

1630

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

175

1.98

3.57

1.0

1.2

29.9

22.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

554

4659

1.18

3.57

2.7

3.5

u/ml

712.8

779.4

0.08

501

4234

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

3492

32514

1.07

3.56

1.5

1.4

—

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

2.58

3.56

1.7

1.5

nmol/l

276.7

212.9

0.18

(3038071) Oxygen [Partial pressure] in Mixed venous blood

526

1.55

3.53

8.2

9.0

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1070

11870

0.89

3.52

1.5

—

(3011325) HIV 1+2 Ab [Presence] in Serum

136

2.11

3.51

1.0

1.1

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

373

1.65

3.48

1.3

1.5

nmol/l

556867.3

201943.2

0.54

310

(40757373) Influenza virus identified in Isolate

458

1.58

3.46

1.7

1.6

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

2.48

3.46

1.1

pmol/l

187.5

223.2

0.22

(3006969) Lambda light chains [Mass/volume] in Urine

3.01

3.46

1.1

1.0

g/l

0.0

0.1

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

3.51

3.42

1.0

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

173

1283

1.34

3.40

2.1

2.0

u/l

200.4

198.3

0.17

173

1274

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

338

2731

1.23

3.36

1.0

1.1

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

347

1.66

3.34

1.3

59.3

53.3

0.40

167

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

565

1.51

3.34

1.2

1.1

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

332

1.67

3.34

1.7

3.3

—

(3027874) Urate [Moles/volume] in Urine

2.55

3.30

1.1

mmol/l

1.2

1.7

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

329

2666

1.22

3.20

1.8

2.0

ug/l

26.1

24.3

0.17

319

2605

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

142

1035

1.36

3.16

2.2

2.7

au/ml

153.6

153.9

0.00

151

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

2.64

3.16

10.4

7.7

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

184

1.88

3.13

1.1

1.0

u/ml

0.0

0.6

2.00

167

(3052592) Norovirus Ag [Presence] in Stool

442

1.55

3.04

1.3

—

(21494814) CD8 cells/100 lymphocytes in Specimen

139

1018

1.35

3.02

1.6

2.1

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

152

1132

1.33

2.96

2.8

3.2

mg/l

7.9

8.1

0.14

117

902

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

306

2485

1.22

2.95

1.1

1.2

mg/l

42.0

41.7

0.03

263

2073

(1617658) Protocol used for examination of sentinel lymph nodes

161

2084

0.76

2.95

1.0

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

160

1203

1.32

2.93

1.1

1.2

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

108

1480

0.72

2.92

1.3

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

2.44

2.89

1.1

mmol/l

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

3701

38600

0.94

2.87

2.8

2.9

ug/l

0.7

3.06

2434

24617

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

287

2324

1.22

2.86

1.0

1.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

296

2406

1.22

2.85

1.0

1.1

mg/l

232.0

254.7

1.30

261

2110

(40768806) Pleura Pathology biopsy report

251

2005

1.24

2.84

1.6

1.5

—

(3010503) CD19 cells [#/volume] in Blood

205

1600

1.27

2.84

2.3

2.6

e9/l

0.2

0.3

0.53

197

1559

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.19

2.82

1.1

1.4

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

404

1.55

2.79

1.8

pmol/l

40.8

45.3

0.20

339

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

273

1.67

2.79

1.1

1.2

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

614

1.44

2.77

1.1

u/ml

2.8

1.4

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

281

1.66

2.77

1.3

mmol/l

0.7

1.4

1.06

181

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

673

1.41

2.75

1.1

—

(3035082) Kappa light chains [Mass/volume] in Urine

2.62

2.73

1.1

g/l

0.0

0.2

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

2.37

2.73

1.0

1.2

ng/l

1524.8

4043.4

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

127

936

1.34

2.69

2.4

3.0

umol/l

29.7

28.5

0.52

730

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

152

1150

1.31

2.69

1.1

1.2

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

424

1.52

2.68

1.1

1.4

ng/l

68.6

318.9

0.63

258

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

143

1074

1.32

2.67

1.7

1.9

182.3

155.4

2.00

136

1013

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

202

1.77

2.67

1.5

1.4

pmol/l

7.6

14.5

1.34

167

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

216

1711

1.25

2.66

2.4

1.7

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

141

1058

1.32

2.65

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

262

1.66

2.65

1.0

1.2

—

(3003338) MCHC [Mass/volume]

23869

238891

0.96

2.65

25.2

15.5

g/l

329.9

332.8

307.65

23698

237225

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

2.57

2.64

1.3

1.0

u/field

1.0

1.3

0.41

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

2.48

2.64

1.0

1.4

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

225

1.72

2.64

1.2

—

(44786800) Granulocytes/100 leukocytes in Body fluid

226

1.71

2.60

1.3

22.7

26.5

0.31

175

(3001218) Citrate [Mass/time] in 24 hour Urine

3.10

2.60

1.4

1.3

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

341

1.57

2.59

1.1

1.0

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

2.31

2.59

1.1

1.3

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1003

10955

0.90

2.58

2.1

1.9

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

114

833

1.36

2.57

2.8

3.2

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

138

1038

1.32

2.57

1.1

—

(3000219) Insulin receptor Ab [Presence] in Serum

7.07

2.53

1.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

677

1.39

2.51

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

327

2723

1.19

2.49

3.8

4.7

u/ml

117.1

105.4

0.11

859

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

2.48

2.47

11.7

7.2

45.1

46.4

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

238

1.67

2.44

1.0

1.1

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

179

1.77

2.43

1.0

1.1

u/ml

0.4

1.2

0.69

125

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

100

1341

0.74

2.42

1.0

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

211

1690

1.24

2.40

1.1

u/l

1.2

1.0

0.44

736

(40762887) Creatinine [Moles/volume] in Blood

2.64

2.40

1.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

625

1.40

2.39

1.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

144

1.86

2.38

2.4

2.2

—

(4027681)

239

1943

1.22

2.36

1.2

1.3

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

357

1.53

2.36

9.8

7.5

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

323

2703

1.19

2.35

1.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

196

1.72

2.34

1.0

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

4.08

2.33

1.0

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

618

5433

1.13

2.30

1.1

u/ml

2.0

2.2

0.20

155

1333

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

165

1294

1.26

2.28

1.1

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

161

1.78

2.27

1.3

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

507

1.43

2.26

1.1

—

(3009015) Lactate [Moles/volume] in Synovial fluid

236

1.64

2.26

1.4

1.2

mmol/l

5.7

6.1

0.15

115

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

178

1411

1.25

2.25

1.1

miu/ml

1608.0

1495.9

0.63

178

1411

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

693

1.36

2.22

1.2

—

(3034426) Prothrombin time (PT)

133

1019

1.29

2.22

1.3

1.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

520

1.41

2.17

1.4

1.3

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

325

1.52

2.16

1.8

1.7

mg/l

2.0

1.6

0.87

269

(40758358) Immune stain study

114

1.91

2.14

1.0

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

114

1.91

2.14

1.1

1.4

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

143

1.80

2.11

1.0

1.1

u/l

35.4

60.7

1.40

114

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

141

1097

1.27

2.10

1.6

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

141

1097

1.27

2.10

1.6

1.5

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

126

969

1.29

2.07

1.0

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

338

1.49

2.04

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

274

2299

1.18

1.99

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

274

2301

1.18

1.98

1.2

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

117

898

1.29

1.97

1.8

1.7

u/ml

4029.9

34080.5

1.15

108

(3038177) Helicobacter pylori Ab [Presence] in Serum

562

4969

1.12

1.96

1.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

2687

25319

1.06

1.95

2.0

1.9

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

111

1.87

1.94

1.6

u/l

0.0

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

273

2296

1.18

1.94

1.2

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

334

1.48

1.94

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

591

1.36

1.93

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

170

1.69

1.93

1.2

1.1

u/l

9.2

9.9

0.09

170

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

238

1986

1.19

1.87

1.7

2.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

2117

19850

1.06

1.85

1.8

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

275

2326

1.17

1.84

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

186

1519

1.21

1.84

1.2

1.3

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

210

1736

1.20

1.84

1.5

—

(3029075) Extractable nuclear Ab panel - Serum

113

873

1.28

1.83

1.1

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

134

1058

1.26

1.82

1.9

2.0

mg/l

7.2

9.5

5.83

108

850

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

274

2321

1.17

1.81

1.2

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

299

1.49

1.81

2.8

3.4

umol/l

37.2

42.3

0.91

257

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

274

2323

1.17

1.80

1.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

668

1.32

1.79

1.1

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

110

851

1.28

1.77

1.3

1.2

24.5

21.3

0.15

149

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

678

1.32

1.77

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

517

1.36

1.75

1.1

1.2

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

230

1.55

1.74

1.0

1.1

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

246

1.53

1.73

1.4

1.3

u/l

82.0

335.6

0.76

184

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

165

1342

1.22

1.73

1.2

1.3

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

155

1253

1.23

1.72

1.2

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

524

4657

1.12

1.72

1.2

1.1

au/ml

17.2

10.5

0.52

327

(4212803)

184

1.62

1.71

1.2

1.1

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

2.48

1.71

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

511

1.36

1.71

1.4

1.2

ug/l

336.8

310.6

0.03

279

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

462

5122

0.89

1.69

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

412

3614

1.13

1.69

1.7

—

(40765089) Chromosome analysis panel - Blood by G-banded

985

0.75

1.69

1.0

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

147

1.68

1.67

1.0

1.1

u/field

1.1

1.2

0.34

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

281

1.48

1.66

1.1

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

2.04

1.65

1.0

1.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

265

1.50

1.65

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

111

870

1.26

1.64

1.5

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

168

1378

1.21

1.63

1.3

55.5

66.1

0.66

166

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

159

1903

0.83

1.63

1.3

g/l

1.4

1.5

—

101

(3005011) Chlamydia sp Ab [Titer] in Serum

406

1.39

1.62

1.6

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

109

854

1.26

1.62

1.8

1.7

au/ml

184.4

129.8

0.52

105

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

398

1.39

1.62

6.4

7.4

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

164

1.63

1.61

1.3

1.4

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

260

1.49

1.58

1.6

mg/l

0.6

2.1

4.03

165

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

691

1.29

1.57

1.2

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

159

1305

1.21

1.55

1.5

1.6

iu/ml

2015256.8

1888568.1

0.03

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

684

1.29

1.55

1.2

1.1

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

143

1.66

1.55

1.3

1.6

ug/g

182.8

171.8

0.11

123

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

2.18

1.53

1.0

1.2

—

(3050794) Legionella sp Ab [Presence] in Serum

214

1.53

1.52

1.2

1.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

644

1.29

1.50

1.1

1.2

76.2

74.9

0.05

163

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

644

1.29

1.50

1.1

1.2

103.4

85.8

1.88

167

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

347

3039

1.13

1.50

1.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

719

6544

1.09

1.50

1.3

—

(3003157) Bacteria [#/volume] in Mother's milk

1.93

1.44

4.1

7.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

158

1865

0.84

1.44

1.2

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

2.29

1.41

1.9

4.8

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

2.10

1.41

1.0

1.1

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

334

1.39

1.40

1.0

u/ml

0.0

0.2

2.68

194

(3001964) Herpes simplex virus Ag [Presence] in Specimen

105

837

1.24

1.39

1.4

1.5

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

2.91

1.34

1.0

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

254

1.44

1.33

1.5

1.6

mg/l

2.1

1.6

0.35

177

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

254

1.44

1.33

1.5

1.6

mg/l

1.1

2.3

1.59

162

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

254

1.44

1.33

1.5

1.6

mg/l

0.4

1.0

1.87

168

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

254

1.44

1.33

1.5

1.6

mg/l

1.3

2.7

1.22

173

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

254

1.44

1.33

1.5

1.6

mg/l

1.9

2.5

0.37

171

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

254

1.44

1.33

1.5

1.6

mg/l

0.9

1.2

0.46

156

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

254

1.44

1.33

1.5

1.6

mg/l

2.5

2.1

0.16

184

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

254

1.44

1.33

1.5

1.6

mg/l

0.8

2.2

2.57

148

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

254

1.44

1.33

1.5

1.6

mg/l

3.0

3.8

0.38

157

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

279

1.42

1.33

1.3

13.1

13.8

0.05

145

(3044009) aPTT.lupus sensitive (LA screen)

279

1.42

1.33

1.3

1.2

—

(3017509) Phencyclidine [Presence] in Urine

363

1.36

1.32

2.0

1.6

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

219

1880

1.15

1.31

1.6

1.9

mg/l

4.7

3.4

2.95

205

1798

(3003740) Influenza virus B Ag [Presence] in Specimen

466

5076

0.91

1.30

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

102

818

1.24

1.30

1.1

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

215

1.47

1.29

1.3

1.2

nmol/l

16.4

15.6

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

2.48

1.28

1.5

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

290

1.40

1.27

1.1

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

392

3503

1.11

1.25

1.7

titre

5297.8

2729.8

—

122

(3002523) Influenza virus A Ag [Presence] in Specimen

467

5073

0.91

1.25

1.1

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

453

1.31

1.25

2.1

4.8

u/l

58.6

58.5

0.00

168

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

283

1.40

1.25

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

104

841

1.23

1.24

1.6

2.2

e6/l

282.6

329.3

0.13

457

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

210

1.46

1.22

1.0

u/ml

2.0

0.9

0.21

131

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

194

1.48

1.21

1.7

1.4

26.0

35.1

0.56

127

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

1.89

1.19

1.0

u/l

142.5

386.4

1.12

(3019174) dRVVT (LA screen)

269

1.40

1.19

1.2

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

227

1972

1.14

1.18

1.2

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

253

1.41

1.18

1.1

1.2

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

220

1.44

1.17

1.3

1.2

—

(3017958) Strawberry IgE Ab [Units/volume] in Serum

1.70

1.17

1.0

u/ml

0.0

0.1

1.37

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

304

1.37

1.16

1.0

u/ml

0.1

0.4

0.80

168

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

313

1.36

1.15

1.0

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

442

1.30

1.15

1.1

—

(3011897) Casein IgE Ab [Units/volume] in Serum

503

1.28

1.15

1.1

1.2

u/ml

0.1

9.8

1.57

105

(3020356) Listeria sp identified in Specimen by Organism specific culture

238

1.42

1.14

1.3

1.1

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

197

1.46

1.14

1.0

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

331

1.35

1.13

1.0

1.2

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

306

1.36

1.12

1.0

1.1

—

(3006245) CD3-CD19+ cells/100 cells in Blood

135

1133

1.18

1.12

1.7

2.2

11.1

9.9

0.52

130

1051

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

393

1.31

1.10

1.3

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

150

1.52

1.09

1.1

1.0

—

(3035933) Granulocytes/100 leukocytes in Blood

844

0.80

1.09

1.5

1.7

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.69

1.07

1.1

1.0

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

1.93

1.07

1.0

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

353

1.32

1.05

1.0

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

167

1435

1.15

1.05

1.7

2.0

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

216

1893

1.13

1.02

1.0

—

(3005067) clonazePAM [Moles/volume] in Serum or Plasma

2.25

1.02

1.2

1.4

nmol/l

66.8

73.7

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

312

1.33

1.02

1.0

u/ml

0.2

1.6

0.61

163

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

187

2107

0.88

1.02

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

129

1.54

1.01

3.1

3.2

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

482

4406

1.08

1.01

1.1

u/ml

5.7

4.7

0.31

202

1795

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

1.90

1.01

1.2

1.3

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

1.90

1.01

1.0

1.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

170

1.46

1.00

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

154

1.48

0.99

1.1

—

(36303858) Crystals [Presence] in Urine

1.98

0.99

1.1

1.2

—

(3032868) Hemoglobin electrophoresis panel in Blood

246

1.37

0.98

1.6

1.5

—

(21494434) Karyotype in Bone marrow

216

1902

1.13

0.96

1.1

1.2

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

359

1.30

0.95

1.3

1.6

—

(21494815) CD4 cells/100 lymphocytes in Specimen

265

2363

1.11

0.95

1.9

2.2

43.2

41.9

0.25

310

(3047185) IgG [Mass/volume] in Urine

1.79

0.95

1.1

1.0

—

45.2

—

(3016031) Almond IgE Ab [Units/volume] in Serum

214

1.39

0.94

1.1

1.0

u/ml

0.1

0.7

2.77

111

(3049233) Organic acids panel - Urine

2.20

0.93

1.0

1.1

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

645

1.21

0.92

2.0

2.7

ng/l

84.8

107.3

0.68

336

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

417

3807

1.09

0.92

1.1

1.0

u/ml

0.2

0.4

1.19

111

778

(40758292) HTLV I+II Ab panel - Serum

461

0.75

0.92

1.1

1.4

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

125

1064

1.16

0.92

1.1

ng/l

352.0

511.6

0.35

246

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.67

0.92

1.0

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

224

1985

1.12

0.91

2.3

2.6

e6/l

903.0

683.0

3.57

110

800

(3003721) Smooth muscle Ab [Units/volume] in Serum

217

1.37

0.88

1.1

—

2.3

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

192

1.39

0.88

1.2

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

286

1.32

0.87

1.0

u/ml

0.0

0.4

2.23

161

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

1.98

0.86

1.0

1.2

—

(40768795) Lymph node Pathology biopsy report

232

2547

0.90

0.86

1.1

1.2

—

(3014891) Appearance of Pleural fluid

236

1.34

0.84

1.7

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.59

0.84

1.1

nmol/l

265.9

242.6

0.15

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

110

0.54

0.83

1.3

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

111

0.54

0.83

1.0

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

170

1.40

0.81

1.3

1.4

—

(3015350) Toxocara sp Ab [Presence] in Serum

1.86

0.81

1.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

531

1.21

0.79

1.1

—

(3045759) Histamine [Moles/volume] in Serum or Plasma

0.00

0.79

0.0

1.5

—

(3009992) Blasts/100 cells in Bone marrow

0.00

0.79

0.0

1.8

—

15.7

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

695

1.18

0.78

1.0

1.1

mg/g

6.3

6.5

0.21

657

(3021691) Plasmodium malariae Ab [Titer] in Serum

1.80

0.78

2.2

2.3

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

138

1.44

0.78

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

302

1.28

0.76

2.3

2.2

u/field

0.8

0.6

0.41

302

(3032743) Legionella sp IgG Ab [Presence] in Serum

164

1.39

0.76

1.0

1.1

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

1.71

0.75

2.4

2.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

504

4683

1.07

0.75

1.1

u/ml

5.6

4.6

0.32

211

1795

(3017461) Flecainide [Moles/volume] in Serum or Plasma

131

1.44

0.75

1.8

1.6

umol/l

0.7

0.08

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

190

1.36

0.75

1.0

1.1

iu/ml

16.8

15.8

—

(3022475) Manganese [Moles/volume] in Blood

195

0.66

0.74

1.1

1.2

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

304

1.27

0.73

1.0

u/ml

5.3

1.4

0.33

225

(3012920) Ethanol [Mass/volume] in Serum or Plasma

1.59

0.71

2.2

1.3

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

441

0.79

0.71

2.9

3.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

270

1.28

0.71

1.2

1.1

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

440

0.79

0.70

5.8

6.2

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

530

1.20

0.70

1.0

1.1

u/ml

0.4

3.5

1.74

377

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

100

1.49

0.70

6.1

9.6

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

125

1.43

0.69

1.1

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

238

2573

0.92

0.69

3.7

3.8

u/ml

46.0

43.4

0.09

230

2553

(3049242) von Willebrand panel - Platelet poor plasma

1.53

0.69

1.5

1.7

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

179

0.66

0.68

1.0

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

733

1.16

0.68

1.0

1.1

—

(3000285) Sodium [Moles/volume] in Blood

273

1.27

0.66

1.2

1.1

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

212

1.31

0.66

1.1

u/l

19.0

23.0

0.73

139

(3018291) Platelet Ab [Presence] in Serum

1.58

0.64

1.1

1.0

—

(3024869) Neuronal Ab [Presence] in Serum

427

1.21

0.64

1.0

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

873

0.86

0.63

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

171

1.33

0.62

1.0

1.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

817

1.14

0.60

1.7

2.0

—

(3010937) Rubella virus Ab [Presence] in Serum

207

1.29

0.60

1.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

173

1.32

0.58

3.5

5.0

—

(3008536) Aspergillus sp Ab [Presence] in Serum

514

0.83

0.58

1.9

2.4

—

(3013862) HLA-DP [Type]

113

0.61

0.57

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

1.70

0.57

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

1.70

0.57

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

1.70

0.57

2.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

1.70

0.57

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

1.70

0.57

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

1.70

0.57

1.0

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

262

1.25

0.57

1.1

umol/24h

2.2

1.7

1.73

262

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

143

1563

0.91

0.56

2.3

2.7

44.2

39.5

1.73

529

(3028679) Herpes simplex virus Ab [Presence] in Serum

189

1717

1.09

0.56

1.2

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

201

1.28

0.55

1.0

u/ml

0.1

1.5

1.36

153

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

140

1.34

0.55

1.1

1.8

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.47

0.54

1.2

1.1

—

(3022725) Serotonin [Moles/volume] in Serum

1.41

0.54

1.2

1.4

nmol/l

676.1

964.4

0.63

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

1.56

0.53

1.0

—

(3007733) Chloride [Moles/volume] in Urine

1.52

0.53

1.1

1.6

mmol/l

78.7

90.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

544

5138

1.05

0.52

1.6

1.5

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

1.52

0.52

1.0

1.1

—

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

133

1.34

0.52

1.1

1.2

—

14403.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

191

1744

1.09

0.52

5.8

6.6

—

(3006598) pH of Arterial cord blood

1.47

0.51

1.1

—

(4133840)

783

1.13

0.50

1.1

1.2

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

441

1.17

0.49

1.1

1.4

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

350

1.19

0.48

1.1

1.0

—

(40760410) HLA-B [Type] by High resolution

109

0.64

0.48

1.0

—

(40760409) HLA-A [Type] by High resolution

109

0.64

0.48

1.0

—

(46236302) HLA-C [Type] by High resolution typing

110

0.63

0.48

1.0

—

(40763590) HLA-DQ beta [Type]

110

0.63

0.48

1.0

—

(3046861) Legionella sp Ag [Presence] in Urine

118

1.34

0.47

1.3

1.0

—

(3007919) Fasciola sp Ab [Titer] in Serum

1.47

0.47

1.0

1.1

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

480

1.16

0.47

4.3

5.9

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

202

1868

1.07

0.43

1.4

1.3

pmol/l

75.1

85.3

0.17

106

602

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.65

0.42

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

1.41

0.42

2.8

1.2

mmol/24h

2.2

2.3

—

(3020874) Milk IgE Ab [Units/volume] in Serum

215

1996

1.07

0.41

1.1

u/ml

0.6

2.9

1.41

551

(3005082) Progesterone [Moles/volume] in Serum or Plasma

239

2227

1.06

0.41

1.5

1.3

nmol/l

24.0

32.3

5.92

204

2059

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.41

0.0

1.1

—

(3042628) Porphyrins [Moles/volume] in Urine

0.00

0.41

0.0

1.1

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.41

0.0

1.1

—

(40760512) CD34 cells/100 cells in Bone marrow

0.00

0.40

0.0

1.6

—

(3006498) Trichoderma viride IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

107

968

1.09

0.39

1.0

1.1

—

(3013762) Body weight Measured

101

0.69

0.39

1.0

1.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

158

0.75

0.39

1.0

1.1

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

0.00

0.39

0.0

1.1

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

150

1.25

0.37

1.4

1.3

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

276

0.83

0.37

2.0

2.6

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

541

5554

0.96

0.36

1.3

ug/l

3.6

0.11

490

5016

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

306

1.17

0.36

1.0

u/ml

3.8

1.1

0.34

226

(46235168) Fasting glucose [Moles/volume] in Blood

297

1.17

0.36

1.6

2.0

mmol/l

7.3

7.1

0.06

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.65

0.35

1.0

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

410

0.87

0.33

1.1

1.0

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

181

1.20

0.32

1.3

1.4

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.33

0.31

1.4

1.1

2.6

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

164

1.21

0.30

1.0

—

(3022670) pH of Venous cord blood

1.28

0.30

1.1

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

128

1.24

0.29

1.0

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

110

1.26

0.29

15.7

15.3

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

119

1.25

0.29

1.4

1.2

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.26

0.29

1.0

1.1

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.26

0.29

2.4

5.3

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

124

1311

0.94

0.29

5.2

6.0

u/ml

6944.0

3146.1

0.22

263

(3026726) Creatinine [Moles/volume] in Specimen

202

1.18

0.28

2.5

umol/l

242.6

406.3

0.92

195

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

398

1.12

0.28

2.2

2.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

175

1.19

0.27

1.0

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

173

1805

0.95

0.27

1.1

1.0

u/ml

0.4

0.8

0.68

231

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.69

0.26

1.0

—

(3034614) HLA Ag [Interpretation]

1.24

0.25

1.0

1.3

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.24

0.25

1.1

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

190

0.83

0.25

1.4

2.4

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.22

0.25

1.0

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

208

1970

1.05

0.25

1.1

1.0

u/ml

0.8

4.3

1.36

459

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

626

0.92

0.24

1.1

1.3

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

660

1.08

0.24

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

660

1.08

0.24

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

660

1.08

0.24

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

660

1.08

0.24

1.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

123

1.21

0.23

1.2

1.0

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

133

1.19

0.22

1.1

—

(3004560) Lymphocytes [#/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

(3014257) Rhodotorula spp IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3026868) Penicillium brevicompactum IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

(3035411) Chaetomium globosum IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3029889) Paecilomyces variottii IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3013851) Stachybotrys chartarum IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3034707) Cochineal extract IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.9

—

(40761895) Polymorphonuclear cells/100 leukocytes in Peritoneal dialysis fluid

0.00

0.21

0.0

2.3

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

369

1.10

0.21

1.1

1.2

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

284

1.12

0.20

1.2

1.4

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

300

0.89

0.20

2.8

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

1.24

0.20

1.0

1.1

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

164

0.85

0.20

2.7

5.7

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

140

1451

0.96

0.20

1.7

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

333

1.10

0.19

2.5

2.6

—

(3007463) Buprenorphine [Presence] in Urine

136

1.17

0.18

8.6

7.8

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

543

0.93

0.17

1.6

1.9

ug/l

2.0

3.6

0.88

321

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

502

0.93

0.17

1.3

1.7

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

118

1.17

0.17

1.2

1.1

37.2

36.0

0.49

110

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

118

1.17

0.17

1.2

1.1

20.8

21.4

0.21

108

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

118

1.17

0.17

1.1

8.6

8.7

0.10

108

(3020650) Glucose [Presence] in Urine

778

1.06

0.17

1.4

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.73

0.17

1.4

1.1

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

176

1.13

0.15

1.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

170

0.87

0.15

6.1

4.8

—

(3009677) Dengue virus Ab [Presence] in Serum

128

0.85

0.15

1.1

1.2

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

221

0.90

0.14

2.7

3.7

mg/l

2.1

2.2

0.08

193

(40765096) Chromosome analysis panel by Banding

679

0.95

0.14

1.1

—

(3018001) Oat IgE Ab [Units/volume] in Serum

230

0.90

0.13

1.0

u/ml

0.1

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

148

1511

0.97

0.12

1.0

ng/l

237.8

335.8

3.26

109

1092

(3030313) Adrenal Ab [Titer] in Serum

323

1.07

0.12

1.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

149

1520

0.97

0.12

1.0

ng/l

32.3

42.4

3.83

108

1077

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

275

1.08

0.12

1.3

—

(3036071) Salmonella sp Ab [Titer] in Serum

966

0.96

0.11

1.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

149

1518

0.97

0.11

1.0

ng/l

865.3

743.9

2.47

106

1058

(3044416) Complement C4 [Mass/volume] in Pleural fluid

104

1.14

0.11

1.1

1.2

g/l

0.1

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

114

1.13

0.10

1.1

1.0

u/ml

0.1

0.3

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

469

4583

1.01

0.10

1.1

u/ml

3.4

2.9

0.26

196

2330

(3009871) Measles virus Ab [Titer] in Serum

103

1052

0.97

0.10

1.7

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

153

1.10

0.09

1.0

—

(3007542) Rye IgE Ab [Units/volume] in Serum

174

0.91

0.09

1.0

1.1

u/ml

0.7

11.4

0.49

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

184

0.91

0.09

1.0

1.1

u/ml

4.5

6.0

—

132

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

1.10

0.09

1.0

1.3

—

(3029396) Erythrocyte agglutination [Presence] in Blood

110

1118

0.97

0.08

3.2

3.0

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

251

1.07

0.08

1.0

1.1

—

(4038314)

116

1.11

0.08

1.3

1.2

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

174

1.08

0.07

1.0

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

457

1.04

0.07

3.0

2.4

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

928

1.02

0.06

1.2

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

100

0.89

0.06

1.9

3.3

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

100

0.89

0.06

1.6

1.2

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

215

1.06

0.06

1.7

2.7

pmol/l

27.2

61.5

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

528

1.03

0.05

1.1

1.2

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

186

1.06

0.05

1.8

2.4

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

578

0.98

0.04

1.2

1.1

—

(3045142) Bone marrow Pathology biopsy report

257

2526

1.01

0.03

1.2

1.3

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

1.09

0.03

1.0

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

298

2935

1.01

0.02

1.5

—

(3013293) Extractable nuclear Ab [Presence] in Serum

446

1.02

0.02

1.6

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

176

0.96

0.02

1.1

—

(3015183) Erythrocyte sedimentation rate

164

1612

1.01

0.02

1.3

1.2

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

161

1.05

0.02

1.2

1.1

—

(4035726)

2238

22187

1.00

0.01

1.4

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

270

1.03

0.01

2.7

3.0

mg/l

1.5

1.2

0.31

183

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

175

0.96

0.01

1.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1822

18050

1.00

0.00

1.7

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

173

0.97

0.00

1.2

u/ml

0.1

6.3

1.89

144

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

104

0.95

0.00

1.0

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

388

1.00

0.00

1.2

1.3

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

370

0.99

0.00

2.0

1.6

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

108

1.01

0.00

1.1

1.0

u/ml

0.2

0.4

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

578

0.99

0.00

1.2

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

578

0.99

0.00

1.2

1.1

—

(3038702) Sodium [Moles/volume] in Capillary blood

0.00

0.0

4.6

—

140.8

—

(3012864) Amino acids [Identifier] in 24 hour Urine

0.00

0.0

1.2

—

(43054952) inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

9.4

—

(3003220) Varicella zoster virus IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

571.8

—

(3037820) Gliadin IgA Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3027114) Cholesterol [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3020399) Glucose [Mass/volume] in Urine

0.00

0.0

1.7

—

(3017830) Gliadin IgG Ab [Presence] in Serum

0.00

0.0

1.0

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

0.0

1.4

—

(3039621) Maximum lysis.intrinsic coagulation system activated.heparin insensitive [Length fraction] in Blood by Rotational TEG

0.00

0.0

2.5

—

4.0

—

(3032642) Schistosoma sp Ab [Titer] in Serum

0.00

0.0

1.0

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.88

0.00

4.3

3.0

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.93

0.00

1.9

3.2

—

(3025830) Chlamydophila pneumoniae IgM Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.95

0.00

1.0

1.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint E4_OBESITY and mortality.

Females

Parameter	HR [95% CI]	p-value
E4_OBESITY	2.165 [1.95, 2.41]	< 0.001
Birth year	0.993 [0.99, 1.0]	0.088

During the follow-up period (1.1.1998 — 31.12.2019), 8290 out of 89525 females with E4_OBESITY died.

Males

Parameter	HR [95% CI]	p-value
E4_OBESITY	2.128 [1.93, 2.35]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.006

During the follow-up period (1.1.1998 — 31.12.2019), 9824 out of 62365 males with E4_OBESITY died.

Mortality risk

Mortality risk for people of age

years, who have E4_OBESITY.

N-year risk	Females	Males
1	0.18%	0.361%
5	1.077%	2.149%
10	2.722%	5.613%
15	5.357%	10.93%
20	9.317%	18.155%

Relationships between endpoints

↥

Index endpoint: E4_OBESITY – Obesity

GWS hits: 73

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Obesity

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints